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SUMMARY
A study of low voltage polyacrylamide gel electrophoresis (PAGE) 
as a basis for providing controlled drug release has been carried 
out.
Polyacrylamide gels were prepared by chemically initiated 
polymerization and were found to swell and leach U.V. absorbing 
materials in aqueous solutions. The degree of swelling was 
influenced by polymerization temperature, gel formulation and ionic 
strength of immersing solution. Swelling of polyacrylamide gel was 
found to be negligible during electrophoresis.
Rod PAGE showed that it was possible to use lower voltages (e.g. 
5V) than conventional PAGE techniques (typically 100V) to effect 
reproducible electrophoretic migration of proteins such as bovine 
serum albumin and insulin; protein migration was influenced by gel 
formulation and electrolyte buffer ionic strength and pH.
It was found that permeation of drugs such as insulin, hyoscine 
HBr, propranolol HC1 and hyoscine methyl chloride through 
polyacrylamide, could be reduced by manipulation of gel formulation. 
Thus polyacrylamide gel discs were used to provide a "barrier" to 
drug permeation from reservoir solutions. Subsequent application of 
an electric field allowed drug to be eluted from the reservoir.
By use of a stabilized power supply providing constant voltage 
conditions (e.g. 5V), the above drugs could be released at constant 
rates for several days. In addition, Insulin and hyoscine methyl 
chloride could be released intermittently by removal and re­
application of the electric field, with no lag time observed. Drug 
release rates were influenced by applied voltage, temperature and 
polyacrylamide gel formulation.
A study of _in vitro permeation of hyoscine hydrobromide through 
human skin indicated that permeation rate was influenced by donor 
drug solution concentration and pH. Some factors important in a 3- 
compartment model intended for study of controlled jji vitro 
electrophoretic drug delivery to human skin were investigated.
It was concluded that low voltage PAGE appears to be a promising 
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INTRODUCTION
1.1. Controlled drug delivery
Most drugs are currently administered either parenterally or by 
mouth? a typical plasma concentration versus time protile following a 
single oral bolus of drug is shown in figure 1.1a. Plasma drug 
concentration rises initially, peaks, and gradually falls as drug is 
metabolised and excreted. Depending on a drug's biological half life 
and its absorption, distribution and elimination characteristics [1], 
repetitive dosing in the above manner may result in a "pulsing" plasma 
concentration profile (figure 1.1b) where plasma drug levels alternate 
between those causing toxicity and those having no therapeutic action.
"Slow" or "sustained" release preparations have been formulated 
to achieve more desirable patterns of drug release e.g. by use of 
enteric coating agents and special tableting excipients [2]. However 
most of these methods, which retard or slow drug release are 
influenced by environmental conditions and lack inter-patient 
reproducibility [3,27]. Most workers agree that delivery of drugs at 
constant (or zero-order) rates is desirable for the purpose of 
maintaining plasma levels within the "therapeutic window" [4,5,6].
Not all workers agree that zero-order drug delivery is optimal, for 
example Wood [7] suggests that first-order release kinetics as 
observed in matrix delivery devices (section 1.4.1.2.) are desirable 
in some circumstances.
Devices capable of releasing drug in a "controlled" manner for 
prolonged time periods have been termed "controlled release" systems. 
Certain disease states require more complex dosage regimens, e.g. 
diabetes mellitus where a basal insulin level needs to be 
supplemented post-prandially. Sustained and controlled drug release 

















FIGURE 1.1a TYPICAL PLASMA CONCENTRATION VERSUS TIME 



















MINIMUM HERAPEUTIC/—  LEVEL
TIME
FIGURE 1.1b "PULSING" PLASMA CONCENTRATION PROFILE 
DURING REPEATED DOSING BY MOUTH
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1.2. Routes of controlled drug administration
In conventional drug therapy, side-effects often arise from drug 
interactions with non-target tissues [13], so that locating a 
controlled drug delivery system in close proximity to the target 
organ may be beneficial. A number of devices adopt this principle; 
for example, a pilocarpine ocular system for the treatment of 
glaucoma ("Ocusert", Alza Corporation, California, U.S.A.), delivers 
drug to the eye for 1 week when placed under the lower eyelid [3].
An intrauterine progesterone delivery system for contraceptive use 
("Progestasert", Alza Corporation) releases drug at a constant rate 
for at least one year [19]. An intraoral system for fluoride release 
has also been proposed [20]. Irritation caused by the Ocusert system 
has been reported [3] and disadvantages of Progestasert include 
bleeding, the risk of ectopic pregnancy as well as cervical and 
uterine perforations [19].
1.2.1. Drug targeting
Agents capable of locating at specific sites of action have been 
attached directly to drug molecules or to "drug carriers* such as 
liposomes, albumin microspheres and synthetic polymer nanoparticles 
[21,22]. In particular, monoclonal antibodies appear promising 
agents for the targeting of cytotoxic agents to malignant cells. 
However, even in cases where drug targeting agents are used, 
some form of controlled delivery may still be desirable.
1.2 .2. Implants
Some of the earliest work using controlled release systems 
involved the subcutaneous implantation of silicone rubber-
4
encapsulated steroids [23]. Davis [24] attempted to control diabetes 
in rats using polyacrylamide implants which released insulin for 
periods of 2 to 3 weeks; animal weight was determined but blood 
glucose levels were not monitored. In similar work, Creque et al.
[25] preferred ethylene-vinyl acetate copolymer to polyacrylamide on 
the basis of superior biocompatibility (section 13.5.) and 
demonstrated maintenance of normal blood glucose levels in diabetic 
rats for up to a month. However, a major disadvantage of implantable 
devices is the necessity for removal subsequent to useful drug 
release. Biodegradable polymers eliminate this problem, use of these 
materials has been reviewed by Wood [26]. Host work on biodegradable 
systems has been carried out in relation to long acting 
contraceptives. Biocompatibility of polymers is discussed below in 
section 1.3.5.
1.2.3. Oral administration and other routes
Because of the convenience of dosing by mouth, a number of 
sustained-release preparations for oral administration have been 
proposed. Koch-Weser and Schechter [27] were critical of oral 
sustained release devices suggesting that some have been created for 
commercial reasons only and that a reliably performing slow-release 
preparation is justified only when it increases the effectiveness and 
safety of the incorporated drug. A number of constraints are imposed 
by the oral administration route including the "first pass effect", 
drug stability in the gastro-intestinal tract, drug metabolism in the 
gut wall, gut motility and pH [28].
Various routes of drug administration which avoid the hepatic
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first pass effect (and sometimes other constraints imposed by oral 
dosing) have been studied. For example, Morimoto et al. [2 9] 
considered vaginal insulin delivery to be promising whilst the nasal 
delivery of this hormone and other polypeptides has also been 
examined [30,31] but suffers from the problem of tissue irritation.
The rectal route has been widely studied for the administration 
of insulin [32], however emphasis has been directed towards 
enhancement of otherwise unacceptable absorption rates [33-37] and 
long-term continual drug administration via the rectum is of 
questionable value. Although drug absorption by the rectal route is 
generally regarded as avoiding the first pass effect, this may be 
dependent upon a number of factors including absorption site within 
the rectum and drug type [38].
1.2.4. Transdermal drug delivery
The use of skin as a portal for drug delivery has been widely 
studied because of its accessibility and rich blood supply. In 
order to design an efficient transdermal system and to optimise 
transdermal delivery of drugs, an understanding of skin structure and 
function is essential.
1.2.4.1. Skin structure and function
In addition to its role as a container for body fluids and 
tissues, skin performs numerous other functions including that of a 
barrier to the entry of harmful or unwanted molecules from the 
external environment.
Human skin (figure 1.2.) comprises 2 distinct but interdependent 
layers of tissue: firstly, the outermost epidermis, which is
6
SUB-EPIDERMAL








FIGURE 1.2 SCHEMATIC CROSS-SECTION OF HUMAN SKIN, MUCH SIMPLIFIED
unvascularised and approximately 100 urn in thickness over most of the 
body with a range of 60 to 800 um according to anatomical location; 
and secondly, the dermis, which is 3-5 mm thick and interlaced with 
capillaries. Originating deep within the dermis and connecting with 
the external environment through the epidermis are hair follicles and 
sweat ducts [39].
1.2.4.1.1. Stratum corneum (horny layer)
The uppermost layer of the epidermis, the stratum corneum, is 10 
to 5 0 um in thickness and composed of dead, partially desiccated, 
keratinised epidermal cells lying tangentially to the skin surface 
and stacked in highly organised vertical columns. In 1964, Blank 
[40] confirmed earlier postulations that the layer of cells dividing 
the stratum corneum from the remainder of the epidermis formed the 
principal resistance to the penetration of drugs. However, Scheoplein 
and co-workers showed that the horny layer itself was the location of 
molecular impermeability of skin and found the permeability of the 
entire epidermis to be indistinguishable from that of the stratum 
corneum alone [41,47]. Michaels et al. [3 9] proposed a simplistic
2-phase model of the stratum corneum which describes the tissue as a 
dispersion of hydrophilic protein in a continuous lipid matrix 
through which penetrant molecules migrate by dissolution and Fickian 
diffusion. Chandrasekaran found that experimentally determined in 
vitro permeabilities of several drugs through stratum corneum 
conformed to this model [42].
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1.2 .4 .2. Factors Influencing percutaneous drug absorption
It is usually assumed that foetal skin, and skin from elderly 
humans is more permeable than normal adult tissue [43,44] although 
Kligman [4 5] considered age to be unimportant in determining drug 
penetration.
Skin condition may be altered as a result of disease or injury 
when permeability generally increases [46].
Variation in drug absorption rate with anatomical site is well 
documented [47-49] and predictable according to the nature of the 
stratum corneum. Schleupin and Blank [47] ranked the diffusivity of 
simple, small molecules in increasing order of penetration: plantar, 
palmar and dorsum of hand, scrotal and postauricular, axillary and 
scalp, arm, leg and most permeable, the trunk. Shaw and 
Chandrasekaran [50] determined the transdermal flux of hyoscine 
hydrobromide iji vitro using human skin and found increasing order of 
permeability to be thigh, forearm, stomach and chest, back and 
postauricular skin. They considered that the relatively high 
permeability of the skin behind the ear was due to several local 
morphological features including a relatively thin stratum corneum 
and a relative abundance of sweat and sebaceous glands. A 
transdermal system for the delivery of hyoscine hydrobrcmide uses 
postauricular skin as the site of application [42,5054].
Drug may be metabolised within the skin* prior to entering the 
circulation [55].
The normal water content in skin is approximately 40% (w/w) but 
this may be increased severalfold by surface occlusion or immersion 
in water. Hydrated stratum corneum is more permeable to virtually 
all molecules in comparison with skin in the normal state [47]; a
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number of substances, e.g. urea [46], may enhance drug permeation by 
increasing skin hydration.
Drug binding in the skin may be significant, for example, in 
transdermal permeation of hyoscine hydrobromide a "dual sorption" 
model is employed and includes immobile drug molecules bound to skin 
sites and freely diffusing species [3 9]? mathematical analysis allows 
selection of an optimum priming dose of hyoscine hydrobromide to 
rapidly saturate immobilisation sites thus allowing steady state drug 
permeation to become established [42].
Since most drugs are either weak acids or bases, the degree of
ionization will be dependent upon drug dissociation constant and
solution pH [57]. Michaels et al. [39] have shown ^ n vitro, using
«
human skin, that hyoscine hydrobromide (pKa 7 3 5) in the unionized 
form is nearly 20 times more permeable than the corresponding ionized 
molecule.
Because of the lipid-protein nature of the stratum corneum, the 
drug oil/water partition coefficient is often used to predict drug 
skin-permeation behaviour. Highly water-soluble compounds having a 
strong tendency to partition into oils, generally show greatest 
permeation rates [39]? however, it is considered that interpretation 
of partition data may be complicated by drug binding and experimental 
conditions may relate poorly to Jji vivo use.
To increase the range of drugs available for transdermal 
delivery, agents causing a reversible reduction in barrier resistance 
properties of the skin have been studied. A number of such materials 
(usually termed "penetration enhancers") have been identified and these 
include: dimethylsulphoxide (DMSO), pyrrolidones, and surfactants, e.g.
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l-dodecylazacycloheptan-2-one (Azone). Although the precise mechanism 
Is unclear, most penetration enhancers operate by causing some 
physiological and/or chemical change in the stratum corneum. Barry 
[46] outlined properties desirable in an ideal penetration enhancer; 
most importantly, such agents should not cause severe irritation or 
damage to the skin.
1.2.4.3. Methods for the study of percutaneous absorption
Techniques used in percutaneous absorption studies have been 
reviewed by Nugent and Wood [60]. Wherever possible, 
human skin is preferred to animal tissue since physiological 
differences may lead to erroneous comparison; for example, Chowhan 
and Pritchard [61] found that neither rat nor rabbit skin was 
suitable as a model for the percutaneous absorption of naproxen 
through human skin.
It is generally assumed that the stratum corneum provides the 
rate limiting step to percutaneous absorption and therefore most in 
vitro studies employ epidermis or stratum corneum alone rather than 
whole skin. Several techniques have been employed to separate 
epidermis from dermis and stratum corneum from epidermis, including 
heat separation and soaking in enzyme solutions [6 2]. Although 
Swarbrick et al. [63] have recently found that skin samples stored 
frozen show higher permeation rates than fresh tissue, most workers 
employ freezing for skin preparation and storage [39,61,62,215].
In vitro methods to study percutaneous absorption can be divided 
into infinite dose and finite dose techniques:
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( i) Infinite dose technique for studying percutaneous absorption 
of drugs
In this method, skin is mounted as a barrier between two fluid- 
filled chambers which form the donor and receptor compartments. 
Permeation is assessed by periodic sampling of the receptor solution; 
however due to the high initial value, no appreciable reduction in 
donor concentration occurs since only a small fraction passes into 
the receptor, hence the terra "infinite dose".
A typical release profile obtained in a permeation experiment 




Three phases are apparent:
A. Lag phase when drug is not detected in receptor.
B. Non-linear p h a s e  when solute concentration in the receptor 
continuously increases.
C. Linear phase or steady state when flux (J) is constant and can
be calculated from the slope of the linear portion using equation
1.1 [64].
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J = dM = DCo (equation 1.1)
dt h
where M Is the mass of solute diffusing in time t
Co is the solute concentration in the first layer of membrane
contacting the donor solution 
h is the membrane thickness
D is the solute diffusion coefficient in the membrane
The lag time, L, may be obtained by extrapolation of the steady state 
plot to the time axis and may be used to calculate D using equation i-2 
[64].
L = h2 (equation 1.2)
6D
It is usually not Co but Co1, (the initial concentration cf solute 
in the donor solution bathing the membrane) which is measured.
Co and Co1 are related by K, the solute partition coefficient between 
the membrane and bathing solution (see equation 1.3).
Co = Co1K (equation 1.3])
Substituting in equation 1.1 gives equation 1.4 [64]
dM = DCo1K (equat;on 1.4])
dt h
Because of difficulties often experienced in determination of Kin 
biological membranes, the permeability coefficient, P (equatiot 1.5), 
a composite of K and D (see also section 4.4.2.) is often the 
parameter reported in the literature.
P = KD (equaticn 1.5)
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( ii) Finite dose technique for studying percutaneous absorption
Franz [6 5] objected to the infinite dose technique mainly on 
the basis that both surfaces of the membrane are bathed by aqueous 
solution and thus fully hydrated skin is employed; to mimic jji vivo 
conditions more closely a "finite dose" technique was proposed where 
the membrane was bathed only on one surface which was considered to 
model blood supply, whilst the other surface was exposed to a 
controlled environment and to which a given quantity of medicament 
was applied.
1.2 .4 .4. Transdermal drug delivery systems
The Alza Corporation has developed a number of "Transdermal 
Therapeutic Systems" (TTS) which resemble sticking plasters and 
consist of: an outer backing layer; a saturated drug reservoir; a 
diffusion rate-controlling membrane; and an adhesive, drug-containing 
layer contacting the skin surface (figure 1.3). TTS's designed to 
deliver glyceryl trinitrate, clonidine, hyoscine hydrobromide and 
oestradiol have been developed [52,66] and a number of other drugs, 
e.g. propranolol [67] have been studied for future systems. 
Transdermal systems avoid the hepatic first pass effect and also aim 
to lower drug dose and achieve constant plasma levels of drug. 
Pharmacokinetic models have been developed to describe release from 
transdermal rate-controlled devices [6 8,6 9].
Hyoscine hydrobromide has useful anti-emetic action but when 
administered orally or by injection at a dose of 2 00 ug every 6 
hours, may produce unpleasant side effects such as drowsiness, 
giddiness, confusion and mental disturbances [53]. Transderm ally, 











FIGURE 1.3 SCHEMATIC DRAWING OF A TRANSDERMAL 
THERAPEUTIC SYSTEM
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dose in the first few hours to saturate drug binding sites within the 
skin followed thereafter by a constant delivery rate of 5 ug hour”  ^
over the remainder of the 3 day treatment period. The system, of 2.5 
cm^ area is placed behind the ear; hyoscine release rate corresponds 
to 2 ug cm"2 hr"^ which is one fifth of the average permeation rate 
of the drug through postauricular skin [53], thus the system controls 
hyoscine permeation rate through the skin. The system provides 
protection against motion sickness with a reduction in the incidence 
and severity of side effects [51,70] associated with oral or 
intramuscular therapy.
Skin irritation produced by the prolonged application of 
transdermal therapeutic systems has been reported [71].
The penetration of drugs into skin by iontophoresis is discussed 
below in section 1.4 .5.1.
16
13. Polymers used In sustained and controlled drug delivery systems
Synthetic polymers have been important in many of the proposed 
approaches to sustained and controlled drug delivery; a number of 
publications discuss the role of polymeric materials in this respect 
[3 ,5 ,13 ,17 ,72,73] .
1.3.1. Preparation of polymers
Polymerization (and resulting polymers) can be divided into 
addition (vinyl) or condensation mechanisms according to the reaction 
stoichiometry [74]. Most polymers used in drug delivery devices 
are of the former type and comprise repeating monomer units forming a 
carbon backbone. Substituted ethylene generally forms the basis of 
vinyl polymers, substituent groups influencing polymer characteristics; 
preparation is usually by free radical polymerization involving a 
"chain reaction" where monomers add only to molecules containing 
active centres, the monomer concentration steadily decreasing as the 
polymer chain grows [73].
The condensation polymer backbone usually comprises more than 
one element; these materials account for a small fraction of all 
synthetic polymers and have been less frequently used in drug 
delivery systems.
Polymerization reactions can be further classified according to 
the processing technique employed, into either homogeneous or 
heterogeneous methods [73]. The former includes bulk polymerization 
involving only the monomer and initiator, as well as solution 
polymerization where reaction occurs in solvent. Heterogeneous 
systems include emulsion and suspension polymerization methods.
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1.3.2 . Copolymers
Copolymers are composed of more than one type of monomer unit 
(m) and can be produced by addition or condensation polymerization. 
There are 4 main classes of copolymer:
(a) alternating copolymers, with a regular order of monomer species 
in the polymer chain?
(b) random copolymers where sequences of m^ and m2 are arranged 
indiscriminately ?
(c) block copolymers contain long sequences of identical repeating 
units, i.e. (m^nfn^)*1
(d) graft copolymers, in which chain extensions of a second monomer 
occur as branches.
Ethylene-vinyl acetate (EVAc) copolymer and lactic acid-glycolic 
acid copolymer are of the random variety and have been studied for 
use in drug delivery systems [75-77].
1.3.3. Crosslinked polymers
3-dimensional networks can be formed by the incorporation of a 
bifunctional agent to crosslink polymer chains during polymerization. 
Hydrophobic crosslinked polymers such as silicone rubber were amongst 
the first materials used in controlled release devices [23]. In 
196 0, Wlchterle and Lim [7 8] first proposed hydrophilic gels or 
"hydrogels" e.g. poly(2-hydroxyethyl methacrylate) or polyHEMA for 
prosthetic implantation and contact lenses.
Hydrogels are materials which swell in water and other fluids by 
absorbing liquid without dissolving. A number of hydrogels have been 
proposed for use in controlled drug delivery systems [7,72,79,83];
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the most common synthetic hydrogels studied as potential bioraaterials 
are polyHEMA, poly(methacrylamide),. poly(vinyl alcohol), poly(N- 
vinyl pyrrolidone) and polyacrylamide. Polyacrylamide is also 
employed as a supporting medium in the electrophoresis of proteins 
(section 1.5.3.1.).
1.3.4. Characterization of polymers
Molecular weight determination, thermal analysis and mechanical 
testing of polymers are methods routinely employed in their 
characterization [84,]. Evaluation techniques relating more 
directly to the usage of polymers in controlled drug delivery 
systems include solute diffusion through polymers [85,86], swelling 
of hydrogels and polymer biocompatibility (see also sections 13.5. 
and I.4.I.4.C.).
1.3 .5 • Biocompatibility of polymers
A biocompatible polymer may be defined as a material which does 
not adversely affect its biological environment by producing 
undesirable effects such as tissue irritation or more seriously, 
tumours. Clearly, biocompatibility is most important in materials for 
implantation.
Several hydrogels, e.g. poly(HEMA), polyacrylamide and 
poly( glycol monomethacrylate) have been shown to possess good 
biocompatibility characteristics [87-89]. Variations in material 
purity can make comparison of biocompatibility between polymers 
difficult. For example, Langer and Folkman [90] implanted various 
polymers in the eyes of rabbits and found that EVAc caused no 
inflammation whilst polyacrylamide was significantly inflammatory, 
however only the former had been subjected to an exhaustive washing
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procedure.
Bruck [89] considered not only polymer hydrophilicity to be of 
importance in determining biocompatibility but also believed water 
structure both within the gel and on its surface to be important.
Water in hydrogels is believed to exist in at least 3 distinct 
forms [91,92]: bound water, which is hydrogen bojinded to the 
polymer chains? bulk or normal water, which has the properties of 
solvent water; and interfacial water, an intermediate form.
Sprincl et al. [88] suggested that hydrogel physical form may 
affect its biocompatibility, they found that homogeneous gels showed 
superior tissue compatibility to heterogeneous or "phase separated" 
gels. Thus not all factors affecting polymer biocompatibility are 
understood.
20
1.4. Energy sources for producing controlled drug delivery
A controlled drug delivery system operates by the controlled use 
of an energy source to effect drug release. Energy sources wnich 
can be used in drug delivery devices include: physicochemical (e.g.
diffusion, osmosis, dissolution and biodegradation), mechanical, 
electrical and magnetic energy.
1.4.1. Diffusion (in polymers)
To date, diffusion has been the main energy source employed in 
polymeric drug delivery systems and may be described as the tendency 
for gases or solutes to spread uniformly throughout a medium under 
the driving force of a concentration gradient; diffusion is a direct 
result of Brownian motion. Barrer [93] considered the diffusion 
phenomenon in polymers to result from changes in thermal energy 
within the polymer which when sufficiently high, allow the diffusing 
molecule to move between the polymer chains. The "free volume* 
theory-of Kumins and Kwei [94] states that fluctuating local density 
in the polymer creates free volume which if large enough, allows the 
diffusant to move into it. With both theories, the passage of a 
large molecule through a polymer would be expected to be slower than 
for a small molecule.
By analogy to heat conduction, Fick's first law of diffusion 
relates to the mass transfer rate or flux, J, of a solute across a 
plane of area A (equation 1.6).
dM = J = -DA dc (equation 1.6)
dt dx
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where M is the mass of solute diffusing in time t
D is the diffusion coefficient for the solute in the system.
dc is the concentration gradient of the solute across the
dx
diffusion path.
A negative sign is used in equation 1.6 since diffusion is from a 
high concentration to a low concentration region (until an 
equilibrium state is reached).
Variation in diffusion coefficients of solutes through polymers 
is marked and dependent upon a number of factors, e.g., temperature, 
polymer state, solute molecular weight and size.
The release of solute from polymeric drug delivery systems can 
be divided into 2 main types and it is appropriate to consider (i) 
drug diffusion from matrices and (ii) drug diffusion across membranes 
(i.e., from reservoir devices).
1.4.1.1. Diffusion across membranes
The majority of reservoir drug delivery systems comprise a 
saturated drug solution or suspension enclosed by a polymeric 
membrane; the undissolved drug acts as a constant source of solute 
available for diffusion. If sink conditions prevail and there are no 
diffusion effects in the boundary layer, then drug release per unit 
surface area from a capsular reservoir may be defined by equation 1.7 
[95] .
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J = dM = D Cs (equation 1.7)
dt x
where Cs is the solubility of drug in the polymer 
x is the membrane thickness
It can be seen from equation 1.7 that the release rate is a 
linear function of both drug solubility in the polymer and membrane 
diffusivity and inversely proportional to membrane thickness and 
exhibits zero-order kinetics over the useful lifetime of the device. 
Modifications to equation 1.7 may be required according to specific 
system characteristics.
Initial lag or burst effects may be observed if the system is 
used before a concentration gradient is established within the 
membrane or if saturation of the membrane occurs during storage [96]. 
After some time, release rate will fall since the mass of solute per 
unit volume in the core will approach the solubility of the drug.
A number of systems utilising a membrane to control drug release 
have been proposed and many of these are currently in use: 
several intrauterine controlled delivery devices release 
contraceptive hormone e.g. Progestasert [19]; the Ocusert therapeutic 
system [3] also uses ethylene-vinyl acetate copolymer to control drug 
diffusion thereby delaying the delivery of pilocarpine to the eye for 
the treatment of glaucoma; drug reservoir devices in the micron size 
range (microcapsules) have been proposed for the release of 
pilocarpine for ocular therapy [97]; reservoir devices for 
transdermal use are discussed above in section 1.2.4.4.
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1.4 .1.2 Diffusion fron matrices
Matrix devices usually comprise a dispersion of drug particles 
or crystals within an inert polymer matrix. Higuchi [9 8] developed 
equation 1.8 to describe solute release from a planar system having a 
homogeneous matrix.
0.5
Q = (D t (2T - Cs)Cs) (equation 1.8)
where Q is the amount of drug released per unit 
area after time t 
T is the total amount of drug in the polymer matrix
Higuchi suggests that the model would be suitable only where T 
exceeds Cs by a factor of 3 or 4, i.e., when most of the drug is 
present as solid or dispersed particles, in which case equation 1.8 
reduces to equation 1.9.
0.5
Q = ( 2Cs D T t) (equation 1.9)
Dispersed drug particles must first dissolve in and then diffuse
through the polymer network before being eluted from the matrix
surface. A depletion zone arises at the surface and becomes thicker
as elution continues towards the centre of the matrix. Thus the
diffusion path length increases with time and drug release becomes
0.5
time dependent; a linear Q - t relationship is observed.
Controlled release matrix devices have been proposed for the 
delivery of a number of drugs, e.g., steroids from vaginal rings [99] 
and from silicone polymer matrices [100]. A number of workers have
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attempted to achieve zero-order release kinetics from matrix drug 
delivery devices by variation of matrix geometry and use of 
impermeable coatings [75,101].
1.4.1.3. Diffusion from porous matrices
Capillaries or channels filled with solute particles may result 
if a sufficient drug loading is attained [12,73]; in an inert 
hydrophobic matrix, drug permeation through the polymer is negligible 
and occurs instead by dissolution and diffusion through the channels 
and pores following the influx of water (e.g. body fluids). Equation 
1.10 was developed by Higuchi [9 8] to describe release from porous 
matrix tablets.
0.5
Q = (DaE( 2T-ECa)Cat) (equation 1.10)
r
where Ca is the solubility of the drug in the permeating fluid.
Da is the diffusion coefficient of the drug in the
permeating fluid.
E is the polymer porosity factor,
r is the polymer tortuosity factor.
The terms E and r are used to describe the channels and pores in 
individual systems.
Porous matrices have been developed for administration of drugs 
by the oral route using plastic matrix tablets [102] and by 
implantation using EVAc [103].
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1.4.1.4• Diffusion in hydrogels
The hydrophobic polymers described in sections 1.4.1.1. to 
1.4.13. have minimal interaction with water, whereas hydrogels have a 
significant aqueous content. Diffusion in gels was recently reviewed 
by Muhr and Blanshard [104] and covered a spectrum of gels ranging 
from one-phase solutions where "pores" are neither constant in size 
or location, to two-phase or heterogeneous rigid-porous structures; 
release profiles from the latter type being similar to those obtained 
from porous devices (see section 1.4.1.3.).
A number of factors affect solute diffusion in gels [104] and 
these Include: obstruction by polymer molecules; hydrodynamic drag 
at the polymer-solvent interface; alteration of solvent (water) 
properties by the polymer; and polymer-solute interactions such as 
binding.
Hydrogels are permeable to hydrophobic as well as hydrophilic 
solutes, and drug transport can occur by a "pore mechanism" whereby 
diffusion occurs through bulk water within the pore network or by a 
■partition mechanism" [82] similar to that described above (section
1.4.1.2.) involving dissolution and diffusion in the polymer.
Several factors affecting solute diffusion in hydrogels are discussed 
belcw:
(a) Hydrogel water content and solute diffusion
Davis [86] developed an equation which can be used to estimate 
the diffusion coefficient of a solute in a hydrogel from its 
diffusion coefficient in water (equation 1.11).
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D = Do exp (-(0.05 + 10“^M)P) (equation 1.11)
where D is the diffusion coefficient of solute in polymer
Do is the diffusion coefficient of solute in water
M is the molecular weight of the solute
P is the percentage of polymer in gel
Yasuda et al. [105] have also shown that diffusion through 
hydrogels, e.g. poly(HEMA), will increase with increasing hydration.
The pore mechanism predominates in strongly hydrated hydrogels 
whereas the partition process plays an increasingly important role as 
the degree of hydration decreases [83] and becomes even more 
significant for larger solutes [80],
(b) Crosslinking in hydrogels and solute diffusion
Increased crosslinkage in hydrogels results in a reduced pore 
size and a decreased fraction of boMK water; consequently solute 
diffusion coefficients decrease and the partition mechanism may 
dominate the permeation process [106-108].
(c) Hydrogel swelling and solute diffusion
A problem which is characteristic of diffusion in gels is that 
the gel volume may not remain constant because the gel has not 
reached an equilibrium degree of swelling, indeed swelling may be 
caused by the progress of solute diffusion. The drug 
release rate is modified by the extent of hydration of the drug- 
polyraer device, and the nature and concentration of the drug modifies 
the rate and extent of hydration.
A hydrogel is capable of imbibing water and simultaneously 
releasing enclosed drug, the diffusion of solute may be slowed by a 
countercurrent caused by water uptake by the hydrogel [83,110].
Complete mathematical analysis of drug release from swelling 
hydrogels is difficult because diffusion is accompanied by a change 
of phase with a moving boundary separating the phases. Lee [109] 
solved certain moving boundary problems encountered during solute 
release from hydrogels and obtained approximate solutions which 
compared well with available exact solutions. A square root of time- 
dependency for drug release rate is predicted by a model derived by 
Peppas et al. [110] which considers swellable hydrogels exhibiting 
significant volume expansion but with constant drug diffusion 
coefficients. Good [83] described a mathematical model employing 
time-dependent drug diffusion coefficients with continuous swelling 
but at a constant total volume.
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1.4 .2. Osmosis
Separation of a solution from pure solvent by a semipermeable 
membrane (allowing only the permeation of solvent molecules) leads to 
the phenomenon of osmosis where solvent passes spontaneously into the 
solution so that an osmotic pressure is set up [111].
Probably the simplest osmotic delivery system was first 
described by Theeuwes and Higuchi in 1974 ("OROS") and comprises a 
drug reservoir enclosed by a semiperm eable shell [112]; the device 
outwardly resembles a tablet. After administration, an osmotic 
pressure is created within the device by the influx of water from the 
gastro-intestinal fluids and drug solution is expelled through a 
laser-drilled aperture in the wall of the device.
OROS-indomethacin was the first oral osmotic system introduced 
in Europe but was quickly withdrawn due to problems caused by 
adherence of the device to the gut wall leading to localised drug 
release which produced cases of peptic ulceration with bleeding and 
perforation [113]. Smith et al. have proposed a device with several 
orifices for osmotic drug delivery [114] which may overcome some of 
the problems of highly localised drug release. Recently, Breimer et 
al. [115] studied osmotically controlled rectal delivery of several 
drugs, but concluded that therapy would be limited to treatments of 
relatively short duration.
Virtually all diffusion and osmotically controlled drug delivery 
systems are capable at best of achieving zero-order release kinetics, 
usually according to predetermined rates. Some energy sources which 
may be controlled to provide more variable drug release rates (as may 
be required in certain disease states) are discussed below in 
sections 1.4.3 to 1.4.5.
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1.4.3 Magnetic energy
Langer and co-workers have reported the use of oscillating 
magnetic fields to regulate drug release from polymer matrices 
[3,12,77,116-118] .
Initially, bovine serum albumin (BSA) and magnetic steel beads 
(1.4 mm in diameter) were incorporated in an ethylene-virryl acetate 
copolymer (EVAc) matrix in the form of a slab [3,116]. When exposed 
to an aqueous medium, BSA was slowly and continuously released from 
the polymer by diffusion; application of an oscillating magnetic 
field increasing the release rate by as much as 10C%. However, BSA 
release rate was found to decrease with time due to matrix geometry 
(see section I.4.I.2.). The use of a coated hemispheric system [117] 
containing a magnetic ring inside the polymer matrix achieved a 
constant baseline level release rate with magnetically modulated 
bursts of BSA release on demand.
It has been speculated that the oscillating magnetic field 
causes alternate compression and expansion of drug-containing pores 
thus causing increased release [116] and may also affect the 
macromolecules in some way [77]. Although video recordings have 
shown motion of the polymer material on application of the magnetic 
field [77], the precise mechanism of magnetic action is unclear.
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1.4.4. Mechanical energy
Controlled drug delivery systems utilising mechanical energy are 
usually infusion pumps which generally rely on electrical energy for 
their operation. Those systems using electrical energy more directly 
to control drug delivery are discussed below in section 1.4.5.
The simplest pumps provide continuous and constant-rate drug 
infusion. For example, Boulton et al. [120] found improvement (over 
conventional therapy) in patients with painful diabetic neuropathy 
when treated by continuous subcutaneous infusion of insulin.
Several feedback-controlled infusion systems have been developed, 
e.g. "BIOSTAR" developed by Miles Laboratories, Indiana, USA [121] is 
a computerised system designed to simulate the function of the normal 
pancreas in the regulation of blood glucose levels; insulin Infusion rate 
is governed by results of frequent blood analyses. A drawback with BIO­
STAR and similar systems is their size, making patient mobility difficult, 
thus much effort is currently being devoted to the development of 
implantable drug (especially insulin) delivery systems [122,123,12 4].
Schade et al. [12 2] listed desirable features of an implantable 
insulin delivery system including (a) reliability (b) easy 
implantation and removal (c) long battery life (d) multiple insulin 
delivery rates (e) small size and weight and (f) biocompatibility.
Buchwald et al. [124] overcame the problem of drug depletion in 
implanted devices for the treatment of deep venous thrombosis by 
refilling pump reservoirs by percutaneous injection of heparin, 
however episodes of pump refill-associated haemmorrhage were found.
Some workers such as Sefton et al. [123] consider that currently 
available glucose sensors are inadequate for feedback control and 
favour "open loop* or preprogrammed insulin delivery.
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1.4.5 Electrical energy
Mechanical pumps (section 1.4.4.) are probably the largest users 
of electricity for the purposes of achieving controlled drug 
delivery. An important alternative use of the above energy source is 
for iontophoretic drug delivery:
1.4.5.1 Iontophoresis
The term iontophoresis has been described as "the transfer of ions 
under electrical pressure into the body surface for therapeutic 
purposes" [125]. Charged drug is applied under an electrode of the 
same polarity; a return electrode, opposite in charge to the drug, is 
placed at another body site and current (below pain threshold levels) 
allowed to flow for an appropriate time [126].
The delivery of steroids, local anaesthetics and a beta- 
blocking drug by iontophoresis has been investigated with promising 
results [127-129]. Gangarosa and Park [125] have reviewed the use 
of fluoride iontophoresis for desensitising dentin.
Drugs for administration by iontophoresis must be charged and of 
low molecular weight [128,130]; high molecular weight molecules e.g. 
insulin (m.w approximately 5 800) are currently found to be 
inapplicable by iontophoresis [217].
A bracelet-drug delivery device [13 0] which works on the 
principle of iontophoresis has been developed (’Panoderm", Elan 
Corporation, Ireland).
Iontophoresis differs from electrophoresis in that the former 
term implies passage through the skin while electrophoresis is performed 
in a number of media (section 1.53.1). Electrophoresis has not 
previously been studied as a means of providing controlled drug delivery.
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1.5. Electrophoresis
1.5.1. Electrolysis and ionic migration
When a current is passed through a solution of an electrolyte, 
the ions move towards the electrodes. In a medium where electronic 
conduction does not occur, the whole current may be carried by ions. 
Ionic migration during electrolysis is often called ionophoresis 
[131] and is analogous to electrophoresis which involves the movement 
of charged coarse or colloidal particles in liquid under the 
influence of an applied electric field.
McDonald [56] discussed terminology used to describe the 
electromigration of all types of migrants (e.g. colloidal materials 
such as proteins as well as ionic species) in stabilized media; it 
was considered that nomenclature was considerably confused.
During this study, migration of colloidal and molecular species 
under the influence of an applied electric field is referred to as 
"electrophoresis" if performed using a stabilized electrolyte medium 
such as polyacrylamide gel.
1.5.2. Electrokinetlc phenomena [13 2,13 3]
Electrophoresis is one of 4 related electrokinetic phenomena: 
Electrophoresis involves the motion of a charged surface relative to 
stationary liquid under the influence of an applied electric field; 
electro-osmosis, essentially the opposite of electrophoresis, is the 
movement of liquid relative to a stationary charged surface; the 
sedimentation potential is that created by the movement of charged 
particles relative to stationary liquid; and the streaming potential, 
which is caused by the flow of liquid along a stationary charged 
surface. These phenomena arise due to the nature of the solid-liquid
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interface.
i.5.2.1. Surface charge and the electric double layer [132,133/134]
A material, dissolved or suspended in a polar medium (such as an 
aqueous solution of electrolyte) may acquire a surface charge by 
ionization or ion adsorption. For example, biological raacromolecules 
such as proteins are dispersed in solution as particles of colloidal 
size. These possess a certain electrical charge due to groups 
capable of dissociating electrolytlcally. The net charge of a 
protein is determined by the pH of its medium, and may be modified by 
interaction with small molecular weight ions or other macroraolecules.
Oppositely charged counter-ions are attracted to the particle 
surface by electrical forces whilst co-ions (of like charge) are 
repelled from the surface. By a combination of electrostatic forces 
and thermal mixing, an equilibrium situation results where excess 
counter-ions approach the surface and the remainder are distributed 
in decreasing amounts as distance from the surface increases until 
electrical neutrality prevails.
The electrical distribution at the interface is equivalent to a 
so called "diffuse double layer" of charge (figure 1.4.), the first 
layer being tightly bound and the second which is more diffuse. (The 
diffuse layer of countercharges occurring in ionophoresis is usually 
referred to as an "ionic atmosphere" [131]). The degree of 
attraction between the tightly bound layer of counter-ions (in the 
region bounded by AA' and BB') and the surface is such that the 
movement of the surface relative to liquid results in BB' being the 
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FIGURE 1.4 THE ELECTRICAL DOUBLE LAYER AND THE 
ELECTROKINETIC POTENTIAL AT THE 
SOLID-LIQUID INTERFACE
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potential decreases as distance from the surface increases and at the 
solid surface, AA' (with respect to the electroneutral region of the 
solution) is termed the Nernst potential, the lower potential at the 
shear plane BB' is the electrokinetic or zeta potential, £ , (figure
1.4.). The potential decreases in this manner because counter-ions 
close to the surface act as a screen thus reducing electrostatic 
attraction between the charged surface and counter-ions further away 
from the surface. In the regional BB' to CC', there is still an 
excess of counterions, beyound CC', the distribution of ions is 
uniform and electrical neutrality is obtained.
Increasing the electrolyte concentration or counter-ion valency 
causes the screening effect to increase, resulting in a more rapid 
decrease in potential since the double layer thickness is reduced. 
Depending on the nature of the particle surface and surrounding ions, 
electric potential-distance profiles differing from that shown in 
figure 1.4 may be obtained.
1.5.2.2. Zeta potential and electrophoretic mobility
Electrokinetic behaviour depends upon the potential at the plane 
of shear (£). This is located a small distance further out from the 
surface of the tightly bound layer, or the Stern plane, but the two 
appear experimentally indistinguishable and are generally assumed to 
be identical [131]. Zeta potential is important in the study of 
colloidal dispersions. Since it is the electrophoretic migration 
rate-determining potential, a number of electrophoretic techniques 
have been used to determine zeta potential [131,133].
Gonsider an isolated fluid-suspended particle with a net charge, 
Q; application of a uniform electric field, E, causes an
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electromotive force, QE, to act on the particle. When the particle 
is set in motion from rest, a frictional force, fv acts in the 
opposite direction where v is the particle velocity and f is the 
frictional coefficient. For spherical particles, f is 6 irna, 
according to Stokes' law, where n is the solvent viscosity 
coefficient and a is the particle radius. Die electrophoretic 
mobility of the particle, U, is defined by equation 1.12 and its sign 
is the same as the net charge of the migrating particle [136].
U = v (equation 1.12)
E
The relation of electrophoretic mobility to the zeta potential 
is discussed below:
Huckel [137] approached the problem of electrophoretic mobility 
of a sol particle in an electric field by considering a small sphere 
as a p>oint charge but large enough for Stokes' law to be applicable. 
The total force acting on the unit was taken as the sum of viscous 
drag and electric force. Electrophoretic mobility is given by 
equation 1.13.
U = v = Q (equation 1.13)
E 67rna
The zeta potential, k , at the surface of shear is given by equation 




dimensionless quantity which Is the ratio of radius of curvature to
double layer thickness [13 2]. For a point charge, ka can be
■
neglected, giving the Huckel equation (1.15) for electrophoretic 
mobility.
U = £ c (equation 1.15)
67m
In a second approach, Smoluchowski [13 8] considered the motion of 
liquid in the diffuse part of the double layer relative to that of a 
non-conducting flat surface of a particle whose radius is large and 
double layer thickness small (i.e. large ka). Application of an 
electric field parallel to the surface exerts an electric force which 
is the product of charge and field strength (the assumption was made 
that the decrease in potential with distance from the particle 
surface is governed by the Foisson equation). A viscous force will 
also be exerted and will be proportional to the difference in shear 
rate over the thickness of the liquid layer. By equating the 2 
forces and assuming that permittivity and viscosity are constant 
throughout the double layer, the Smoluchowski equation for 
electrophoretic mobility is obtained (equation 1.16).
D = £ c (equation 1.16)
4irn
Equations 1.15 and 1.16 relate electrophoretic mobility to zeta 
potential but differ by a factor of 4/6; one applies to small ka (<1) 
and the other to large ka (>100). These equations were developed for 
non-conducting rigid spheres moving in a perfect insulator and are
inappropriate to electrophoresis of macromolecules which is performed 
in electrolytic solutions and gels [136]. In addition, account must 
be taken of the ionic atmosphere around the migrating particle which 
leads to relaxation and retardation effects (section 1.5.2 3).
1.5.2.3. Electrophoretic retardation and relaxation
The presence of an ionic atmosphere around a particle results 
in slower electrophoretic mobilities than predicted by equations 1.15 
and 1.16. Local movement of liquid caused by a net movement (in the 
opposite direction to that of the particle) of ions in the mobile 
part of the double layer opposes the particle motion, an effect 
known as electrophoretic retardation. Electrophoretic relaxation 
arises from the distortion of the ionic atmosphere during 
electrophoresis, leading to a net force reducing the particle 
velocity [134].
Henry [13 9] derived a more general electrophoretic equation for 
conducting and non-conducting spheres in a conducting solution, 
allowing for the retardation effect but not accounting for 
electrophoretic relaxation. By assuming that the zeta potential is 
small, the Henry equation can be written as (equation 1.17) :
U = J_c_{f)ka (equation 1.17)
67rn
where f(ka) varies between 1.0 for small ka (Htekel equation) and 
13 for large ka (Smoluchowski equation). Henry also assumed that 
c and n were constant throughout the mobile part of the double 
layer.
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The mobility (U) of a particle is a physical constant under 
defined electrophoretic conditions [13 5]. It can be seen from 
equation 1.12 that the absolute mobility is obtained by dividing the 
migration velocity, v, by the applied electric field, E. 
Electrophoretic equations as described above have application mainly 
in the determination of electrokinetic potentials. Absolute 
mobilities and zeta potentials are rarely used in the electrophoresis 
of proteins in polyacrylamide gels since such studies are usually 
comparative exercises where the term "relative mobility" is 
preferred.
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1.5.3. Applications of electrophoresis
Electrophoresis finds application in studies of colloid 
stability and ion-adsorption where calculation of zeta potentials, 
is involved. Electrophoresis is also widely used for the 
separation and identification of components of protein mixtures.
1.5.3.1. Electrophoresis of proteins
Proteins are ampholytes whose charge is determined by the pH of 
the medium and the number and character of ionizable (amino and 
carboxyl) groups. A protein has zero net charge at its isoelectric 
point (pi) and will not migrate in an electric field.
In the 193 0's Tiselius [140] pioneered electrophoretic analysis 
of protein mixtures, his "moving boundary" method comprised a glass 
U-tube in which dissolved protein mixtures were separated and 
identified. Temperature control was essential to minimise 
convectional boundary disturbances arising from the heating effect of 
the applied current.
Paper electrophoresis [141] became widely used in the 1950's 
with the advantage over Tiselius' method of providing improved 
separation of components of protein mixtures; apparatus normally 
comprising, a paper strip or sheet held between 2 electrolyte tanks. 
The disadvantages of this technique include protein adsorption onto 
the paper, fluid evaporation due to ohmic heating leading to 
increased ionic strengths and electro-osmosis. The latter phenomenon 
occurs because cellulose matrices are generally negatively charged 
[142] and induce a positive charge in contacting water which 
therefore moves under a potential gradient (section 1.5.2.) thus
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influencing the sample mobilities.
Although silica gels had previously been employed as 
electrophoretic media [143], significant improvements in resolution 
were obtained by Smithies [144] using starch gels and later by 
Raymond and Weintraub [145] with synthetic polyacrylamide gels.
Starch, and in particular, polyacrylamide gels minimised 
convection and diffusion disturbances with improved resolution 
attributable to their "molecular sieving" effect (section 1.5.4.1.1.).
1.5.4. Polyacrylamide gel electrophoresis (PAGE)
The use of PAGE for the separation of proteins and nucleic acids 
is now widespread. Protein adsorption and electro-osmosis effects 
are negligible and a range of gels can be manufactured to meet 
specific requirements. There have been numerous publications related 
to PAGE, relevant bibliography is referred to in the following 
text.
1.5.4.1. Formation and structure of polyacrylamide gel
Polyacrylamide gel is formed by the free radical polymerization 
of aery lam ide monomers into long polyacrylamide chains. The 
elongating polymer chains are randomly crosslinked with 
l^KC-methylene-bis- aery lam ide (Bis) resulting in a 3-dimensional 
network structure (figure 1.5) which behaves as a hydrogel (section 
1.3 3). A number of parameters are important in polymerization of 
polyacrylamide gels:
(a) Purity of gel-forming reagents
Good quality reagents are essential since contaminants may
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FIGURE 1.
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adversely affect polymerization and subsequent gel properties.
(b) Initiation of polymerization
Radicals required to initiate polymerization may be produced by 
several methods. The most common system uses a chemical source of 
radicals. Ammonium persulphate produces free oxygen radicals in 
solution by a base catalysed process, using N,N,N',N'- 
tetramethylethylenediamine (TEMED). Free radicals can be generated 
photochemically by use of riboflavin which decomposes to leucoflavin 
(also by base catalysis). Since free bases such as TEMED are 
required, polymerization may be delayed or prevented at low pH's; 
alternative catalyst systems for polymerization at low pH have been 
employed [146].
The rate of polymerization and resulting gel properties 
depend upon concentrations of initiators employed. Generally, the 
lowest catalyst concentrations which produce visible gelation within 
15-20 minutes using TEMED and 3 0-6 0 minutes using riboflavin-based 
systems have been found acceptable [147]. Excess amounts of 
initiators have been shown to damage proteins and cause artefacts in 
PAGE [14 8,14 9].
(c) Polymerization temperature
The polymerization reaction is exothermic to the extent that 
highly concentrated or large diameter polyacrylamide gels produce 
considerable heat. The high temperatures lead to cavities being 
formed in the gel as a result of dissolved gases; this effect has 
been shown to diminish when the temperature of the gel solution is 
reduced to 6°C prior to polymerization [150]. However,
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polymerization at lower temperatures (4°C) may result in the 
production of turbid, increasingly porous and inelastic gels [147], 
these effects possibly being due to increased hydrogen bonding of the 
monomer. However, Gressel et al. [151] found that electrophoretic 
mobilities in PAGE at 22°C increased with increasing polymerization 
temperature.
(d) Oxygen
Molecular oxygen inhibits the formation of polyacrylamide gel by 
acting as a free radical trap; degassing of monomer solutions is 
therefore essential [147]. However, the conversion of riboflavin from 
the flavo to the leuco form actually requires a small amount of 
oxygen [152] although excessive oxygen will inhibit even such 
photochemically initiated polymerization.
(e) Monomer concentrations
The concentrations of monomers employed will influence 
polymerization and the properties of the resulting gels. Hjerten 
[153] introduced the numerals T and C to define gel monomer 
concentrations where T denotes the total percentage concentration 
(w/v) of both monomers (acrylamide and Bis) and C is the percentage 
concentration (w/w) of crosslinker relative to the total monomer 
concentration, T. It is generally accepted that the practical range 
for monomer concentration is between 3T and 30T [147].
1.5.4 .1.1. Polyacrylamide gel density (porosity)
In contrast to electrophoresis in liquid media, polyacrylamide 
gel is capable of distinguishing molecular species on the basis of
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size as well as charge, this phenomenon is termed "the molecular 
sieving effect". Polyacrylamide gel porosity is variable over a wide 
range, indeed gel concentration (T) is selected according to weight 
of molecules undergoing electrophoresis, macromolecules of over 
100,000 Daltons being separated by 3-5T gels (table 1.1.) and 
polypeptides of molecular weight as low as 2000 experiencing molecular 
sieving in 30T polyacrylamide gels [154]. A linear relationship is 
generally found [155,156] in electrophoresis of proteins, between the 
logarithm of relative mobility and polyacrylamide gel concentration 
(T).
1.5.4.1.2. Pore theory
Smithies [157] and Ornstein [15 8] used the terms 'pore' and 
'poreL size' in attempting to explain the retardation of a particle 
migrating through a gel network; a number of theoretical 
approaches have been employed in calculation of average pore sizes:
Ornstein [15 8] calculated that 7.5T and 30T polyacrylamide gels 
should have mean pore diameters of 5 nm and 2 nra respectively.
Raymond and Nakamichi proposed equation 1.18, where the average pore 
diameter, p, is inversely proportional to the square root of gel 
concentration (T) of the polymer with molecular diameter d[15 9]
p = kd (equation 1.18)
where the concentration of the gel is defined by equation 1.19
T = k2d2 (equation 1.19)
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where k is dependent upon the geometric configuration of the 
gel and has a value of 1.5 if crosslinking of polymer strands at 
right angles is assumed. Thus in a 5T polyacrylamide gel (with chain 
strands of 0.5 nm diameter) a pore diameter of 3.8 nm is calculated.
Tombs [16 0] related pore size, gel concentration and diameter of 
cylindrical strands by equation 1.20; for example, a pore size of 2.9 
nm is obtained for a 5T polyacrylamide gel of 0.5 nm cylindrical 
strand diameter.
p + d = >/3Tr5d (equation 1.20)
Considering that many calculated mean pore sizes cannot account 
for the passage of large protein molecules, Tombs [161] introduced 
the concept of a "limiting pore size" which is dependent on the 
proportion of pores larger than a limiting size which the protein 
molecules cannot quite enter.
A number of workers do not favour the pore concept, for example 
Hjerten [16 2] prefers the term "size sensitivity" whilst Hedrick and 
Smith [156] consider that "sieving" does not describe the complex 
physical process responsible for the phenomenon.
Pore theories assume polyacrylamide gel to be composed of a 
rigid matrix not displaced by a migrating particle; however Gordon 
[152] considers that macromolecules may "bend" gel fibres during 
electrophoresis since proteins show very slow rates of diffusion in 
the same gels.
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1.5 .4 .1.3 Electrophoretically migrating species size and shape
Electrophoretic mobility is usually found to decrease with 
increasing particle size. For example, Morris and Morris [163] 
demonstrated such a relationship between mobility and mean molecular 
radius (1.57 to 3.61 nm) of 8 proteins during PAGE. Macromolecular 
conformation is also important, most proteins are considered to be 
prolate ellipsoids [164]. An extreme case is DNA, a long and rigid 
molecule whose electrophoretic mobility is little affected by changes 
in gel porosity since it is believed to migrate in a "serpentine" 
fashion [165] through gels, restricting the passage of spherical 
molecules of higher molecular weight.
Although electrophoresis is generally used in the separation of 
polypeptides, smaller molecules such as antibiotics have been 
separated and identified by means of gel electrophoresis [56,166].
1.5 .4.1.4. Crosslinking in polyacrylamide gels
The concentration of crosslinker (C) influences 
electrophoretic mobility in polyacrylamide gels. For example, 
Rodbard et al. [167] found that protein (e.g. BSA) mobility in PAGE 
fell with rising Bis concentration up to 5-8C and then increased as 
Bis was raised frcro 10 to 50C.
With higher proportions of crosslinker, the polymer chains are 
believed to become crosslinked into increasingly large bundles with 
large spaces between them so the effective pore size is increased 
[154,168]. Previously, it had been stated by Raymond and Nakamichi 
[15 9] that Bis provided only mechanical stability to the gel and did 
not influence pore size.
Although Bis is most widely used, alternative crosslinkers are
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available e.g. N,N'-diallyltartdiamide (DATD) which was found to 
improve mechanical stability and adherence to glass of polyacrylamide 
gels compared with Bis [169] .
1.5.4.1.5. Electron microscopy of polyacrylamide gels
Scanning electron microscope studies of freeze-dried 
polyacrylamide gels [17 0,171] suggest a heterogeneous structure 
consisting of 2 to 10 urn thickness walls surrounding pores of similar 
dimensions, with wall thickness increasing as T is raised. This and 
further work [172,173] suggests that any "sieving" action must occur 
within a finer infrastructure in the walls which are possibly an 
artefact of electron microscopy preparation techniques in any case.
1.5 .4 .2. Swelling of polyacrylamide gel
Polyacrylamide gels usually swell in water or aqueous buffer 
solution and this phenomenon might be expected to considerably 
influence molecular sieving behaviour. However, polyacrylamide gels 
for electrophoresis have been little studied in terms of their 
swelling behaviour.
(a) Mechanism of swelling
A solvent's chemical potential is lowered on addition of solute, 
but application of pressure to the solution can restore the solvent's 
original chemical potential. The crosslinked macromolecular network 
of polyacrylamide gel can be considered as a solute which imbibes 
water (solvent). The resultant swelling is opposed by tension in the
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network and water imbibition ceases when the swelling pressure is 
equal to the osmotic pressure of the gel [7] .'
(b) Some factors affecting swelling of polyacrylamide gels
Boyde [174] confirmed the earlier findings of Richards and 
Lecanidou [17 5] that a minimum of polyacrylamide gel swelling occurs 
at 9-15 T and also found that high initiator concentrations during 
polymerization and high polymerization temperatures favoured 
swelling. Richards and Temple [176] observed that swelling decreased 
with increased crosslinking, C, and proposed a theory indicating a 
relationship between swelling and polyacrylamide gel turbidity. 
However, polyacrylamide gel swelling inconsistent with this theory 
has been reported [17 8].
Changes in the swelling of polyacrylamide gels 'cured' (left in 
polymerization mould) for different lengths of time are believed to 
be due to the formation of a heterogeneous gel structure [168,177]. 
No discussion regarding swelling of polyacrylamide gels during 
electrophoresis has been published.
1.5.4.3. Electrophoretic techniques
PAGE finds greatest application in the separation of mixtures of 
biological macromolecules. These are usually applied as distinct 
bands which gradually separate during the course of electrophoresis 
into their components. From this simple basis, numerous specialised 
PAGE procedures have been developed? some of the more commonly used 
techniques are discussed below.
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(a) Molecular weight determination
A plot of gel density (T) versus the logarithm of a particle's 
electrophoretic mobility (U) or relative mobility yields a straight 
line, where the slope of the line is termed the retardation 
coefficient, KR. This relationship was first demonstrated in starch 
gels by Ferguson [17 8] and later applied to polyacrylamide gels by 
Hedrick and Smith [156] who found a linear relationship between KR 
and molecular weight at least over the range 4 5,000-500,000 Daltons. 
Thus by reference to a number of standard proteins, the 
molecular weight of an unknown protein may be determined by 
measurement of its mobility (or relative mobility).
(b) Gradient electrophoresis
Polyacrylamide gels with a gradient of increasing acrylamide 
concentration, T, are used for molecular weight determinations. 
During electrophoresis, proteins migrate until the decreasing pore 
size impedes further progress, thus "bands” of different molecular 
weight fractions result.
In isoelectric focusing [179], a pH gradient is established 
along the gel and proteins migrate until they align themselves at 
their isoelectric point (pi).
(c) Preparative electrophoresis
Preparative electrophoresis involves the scale up from microgram 
quantities of sample (as applied in analytical electrophoresis) to 
milligrams of protein mixtures where recovery is necessary. 
Preparative techniques may be divided into 2 main classes according 
to recovery procedure:
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(i) Extraction of gel fractions: after electrophoresis, 
separated components are localised by staining of a reference gel.
After cutting the gel into appropriate fractions, the sample is eluted 
by diffusion or further electrophoresis.
(ii) Continuous electrophoretic separation and elution: separated 
components migrate to the end of the gel where they are entrained by
a continuous flow of buffer and are collected individually.
1.5 .4 .4. Materials and methods in PAGE
(i) Electrophoresis apparatus and gels
Although designs of equipment for PAGE are varied, they are 
based on 3 geometric configurations of the gel: (a) horizontal gel 
slabs, (b) vertical gel rods or cylinders, (c) and vertical gel 
slabs.
Gel composition is determined by intended application; 
for example, Andrews [180] suggests polyacrylamide gel 
concentrations suitable for separation of macromolecules according to 









Table 1.1 Separation ranges of polyacrylamide gels of various gel 
concentrations, T.
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Electrophoretic apparatus usually comprises 2 electrolyte 
reservoirs which are connected by a gel, rod gel electrophoresis is 
discussed in greater detail in section 5.
( ii) Localisation of separated components after electrophoresis
A large number of staining mixtures including both universal and 
specific stains are available [181]. Densitometry is usually 
employed for quantitative determination of separated components, 
where either the gels themselves, or negatives of gel photographs, 
are scanned. Components are often localised by radioactive labelling 
and fluorescent 'markers' have been used to monitor protein migration 
during electrophoresis (Appendix 1). Migration velocities are not equal 
but proportional to electrophoretic mobility, thus most workers 
express PAGE results as "relative mobilities".
( iii) Buffers for electrophoresis
PAGE may employ "continuous" or "discontinuous" buffer systems.
In the former, the same buffer ions are present in the gel as in the 
electrolyte reservoirs. In contrast, discontinuous (or multiphasic) 
buffer systems use different buffer ions within the gel compared to 
those in the electrolyte reservoirs. Most multiphasic systems have 
discontinuities in both buffer composition and pH. Ornstein [15 8] 
and Davis [182] introduced the concept of multiphasic buffering to 
improve resolution of sample components by concentration of proteins 
into extremely narrow zones.
Specially formulated synthetic mixtures of "carrier ampholytes" 
are utilised as buffers in isoelectric focusing (section 1.5.43 .b.) 
to maintain a stable pH gradient along the gel [17 9].
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The net charge on a protein is determined by the pH of its 
environment, thus buffer pH will influence electrophoretic mobility 
and is selected to give optimal separation of protein mixtures. A 
universal buffer for electrophoresis is not available and a very 
large number of different acids and bases can be used.
Buffer ionic strength will also influence electrophoretic 
mobility since it affects the electrokinetic potential (section 
1.5.2.). Ionic strengths in the range 0.025 to 1M are usually 
employed in PAGE. Low ionic strengths are found to permit high 
migration rates whilst higher ionic strengths give slower rates of 
migration but sharper zones of separation [135]; Gaal et al. [13 6] 
consider that observations inconsistent with these findings are due 
to the influence of ionic strengtn upon factors such as molecular 
shape and dissociation.
The higher the ionic strength of a buffer, the greater is its 
conductivity, thus more heat is generated. Temperature increases 
result in a lowering of gel viscosity and greater sample diffusion. 
Control of temperature during electrophoresis runs is therefore 
vital.
(iv) Power supplies for PAGE
A direct current (DC) power source is required to create an 
appropriate electric field for electrophoretic migration to occur.
The resistance of the electrophoresis cell may change during the 
course of an electrophoresis experiment due to factors such as 
ionic migration, electrolysis and ohmic heating effects. If the 
electrical resistance changes, then either the voltage or the current
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or both must also change. Most workers agree that either a constant 
voltage or constant current power source should be used for PAGE 
[154,183,184], the latter being preferred. However voltage and 
current will alter as cell resistance changes with both constant 
current and constant voltage supplies respectively; recently, constant 
power supplies and 'pulsing' sources have become available [183,184].
Generally, voltages of at least 100 V or currents of 1 to 3 mA 
per gel are used in PAGE separations; power supplies for 
electrophoresis rated at thousands of volts and hundreds of 
milliamps are available [184].
Application of 40 V to slab gels and less than 20 V cm”^ in 
paper electrophoresis have been termed *low voltage” techniques 
[180,185]. Rod PAGE using voltage levels employed in the present 
study (less than 10 volts) has not previously been reported.
Higher voltages are usually preferred since the increased field 
strength produces higher migration velocities and thus shorter 
running times (equation 1.12) as well as limiting band broadening 
caused by diffusion. How ever, the detrimental effects of extra heat 
generated by the increased current impose practical upper limits to 
the applied electric field.
Since the absolute electric field, E, is not easily determined 
in PAGE [196] and the technique is generally comparative in nature, 
many workers use applied voltage or current to describe 
electrophoresis conditions.
(v) Electrodes and electrolysis
Electrochemical reactions occur at the electrodes during 
electrophoresis. The anode naturally becomes acidic, and the
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cathode naturally becomes alkaline under the influence of an electric 
current [17 9]. The anode and cathode reactions are as follows.
Anode reaction
61^0 ----► 02 + 4Ej0+ + 4e“
Cathode reaction 
4 ^ 0  + 4e“ ----► 2 H2 + 4GH~
With multicomponent buffers as electrolytes, electrode reactions may 
be complex. Platinum is usually employed as electrode material in 
PAGE.
In micro-electrophoresis [186], platinum black electrodes are 
used to minimise gas evolution by adsorption.
Electrode polarization may occur during electrophoresis. The 
total polarization resulting from 2 factors; chemical and 
concentration polarization. In concentration polarization, changes 
in local electrolyte concentrations may alter electrode potentials. 
The chemical reactions involved in the discharge or production of an 
ion give rise to chemical polarization.
The change in electrode potential resulting from polarization is 
called "overvoltage", or "overpotential".
Polarization is not usually considered in PAGE, but can be 
reduced by stirring, decreasing the current density and decreasing 
electrolyte concentration [187].
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MATERIALS AND ANALYTICAL METHODS
2.1. Materials
2.1.1. Drugs
Crystalline Porcine Insulin, specially purified for research 
2.85 x 10* International Units g”^ (lot numbers 615-07 J-256-A and 
615-3U0-13 0) was obtained as a gift from Lilly Research Centre 
Limited, Windlesham, U.K.
Iodine-125 labelled Insulin, batch number B2 82 (Amersham 
International pic, Amersham, U.K).
Bovine Serum Albumin (BSA), batch no. 83C-0340 (Sigma Chemical 
Co. Ltd., Poole, U.K.).
Tritlated hyoscine methyl chloride (Amersham International 
pic), batch TRK.66 6/8.
Hyoscine methyl bromide, batches 43F-05 01 and 123F-063 2 (Sigma 
Chemical Co. Ltd.) was converted into the chloride salt before use by 
means of an ionrexchange technique: An ion-exchange resin (Amberlite
IRA 400 Cl, BDH Chemicals, Poole, U.K.) was packed as a slurry (in 
distilled water) into a 15 cm length, 1 cm internal diameter glass 
column. Plugs of glass wool were placed at each end of the packing 
material. The resin was activated by allowing 50 cra^  of concentrated 
hydrochloric acid (BDH Chemicals) to slowly run through the column
■a 3
followed by 500 cmJ of distilled water to remove excess acid. 5 0 cmJ
-3
of a solution of hyoscine methyl bromide (approximately 0.25 mol dm 
was run through the column 3 times and evaporated to dryness at 50°C.
On the basis of a chemical test for chloride [189] the converted salt 
was used without further purification.
Propranolol hydrochloride B.P. was received as a gift from A.H. Cox 
and Co. Ltd., Barnstaple, N. Devon, U.K.).
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Hyoscine hydrobramide, batch 72F-0567 (Sigma Chemical Co. Ltd.). 
Some of the physical and chemical properties of the above drugs 
which may be of importance in relation to electrophoretic release 
characteristics are given below:
(i) Bovine serum albumin (BSA): a protein often employed as a 
reference standard in PAGE. It has a molecular weight of 
approximately 57000, an isoelectric point (pi) of 5.1 at 2 5°C [181] 
and is prolate ellipsoid in shape with approximate dimensions 15 x 3 
nm [190].
(ii) Porcine insulin: a hormone composed of 2 (A and B) polypeptide 
chains of 5777 molecular weight [191]. The insulin dimer is the 
prevalent form in solution [192] with approximate dimensions of 2 x 4 
nm and an isoelectric point of 5.7 [181]. Porcine insulin is 
produced commercially from the pancreas of the pig and used in the 
treatment of diabetes in man.
(iii) Hyoscine methyl chloride (m.w. 354) is a quaternary ammonium 
compound and thus incompletely absorbed from the gastro-intestinal
+
O-CO-CH-CgHg
tract; the bromide salt has been used in the treatment of gastric and 
duodenal ulcers [193].
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( iv) Hyoscine hydrobrcnlde is a tertiary ammonium tropane
+
0 CH- -NH Br
ch2 0H
O-CO-CH-Cg H5
alkaloid of m.w. 3 84.3 with an acid dissociation constant (pka) 
of 7.35 at 30°C [39]. It has central and peripheral anticholinergic 
actions and has been used for pre-operative medication. Hyoscine 
hydrobromide is found to permeate through skin [39] and has been used 
for the prevention of motion sickness by oral and transdermal 
administration (section 1.2.4.4).
(v) Propranolol hydrochloride has a molecular weight of 295.8
and pKa of 9.5 [194]. Propranolol has a specific blocking action on 
the adrenergic beta receptors and inhibits sympathetic stimulation of 
the heart; it is used in the treatment of cardiac arrythmias, angina 
pectoris and arterial hypertension [193]. Usually administered 
orally, it has recently been suggested that transderm al delivery of 






2.1.2. Reagents used In preparation of hydrogels
The following monomers were used as received:
Acrylamide (batch no. A/0977/30), specially purified for 
electrophoresis (Fisons pic, Loughborough, U.K.).
N,Na-methylene-bis-acrylamlde (Bis), electrophoresis grade (batch 
M/4 811/01, Fisons pic).
2-Hydroxyethyl methacrylate (HEMA), batch no. 2 28071112 (Fluka 
A.G., Fluorochem Ltd., Glossop, U.K.).
Ethylene glycol dimethacrylate (EGDMA), batch no. 2 01529 3 81 
(Fluka A.G.).
Chemical catalysts were utilised without further purification: 
Ammonium persulphate A.R. grade, batch 9 06 26 2 0C (BDH Chemicals). 
N,N,Na,N*-tetramethylethylenediamine (TEMED), S.L.R. grade, batch 
586419OB (BDH Chemicals).
2.1.3 Materials used in high performance liquid chromatography 
(HPLC)
1-heptanesulphonic acid sodium salt, batch 23 (HPLC grade,
Fisons pic).
Tetra-n-butylammonium hydroxide (4C%) solution, batch 981190F 
(Fisons pic).
Methanol (HPLC grade), Fisons pic.
2.1.4. Skin
Skin samples were obtained from Caucasian cadavers (aged 60 
years or more) and were excised from the abdominal region. Samples 
were stored in sealed polythene bags at -4 to -5°C and used within 
one month (see section 7.1.1.).
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2.1.5 Miscellaneous materials
4-Phenylspiro ( f uran-2-[3H], l'-phthalan)-3,3’-dione or 
fluorescamine (Sigma Qiemlcal Co. Ltd.).
Scintillation liquidt'Optiphase safe', batch no. 06 (for LKB by 
Fisons pic, Loughborough, U.K.).
All other chemicals, solvents and reagents were of "analytical 
reagent’ quality wherever possible.
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2.2. Analytical methods
2.2.1 U.V. spectrophotometrlc assay of porcine insulin
Most polypeptides exhibit wavelengths of maximum absorbance in 
the U.V. region and therefore ultraviolet spectrophotometry is often 
utilised as a convenient method for the assay of proteins.
Drug solutions were prepared by dissolving insulin in 0.025M 
phosphate buffer (pH 7.4) to provide a concentration range of 2.85 to 
22.80 International Units (I.U.) cm"^. Using 1 cm path length quartz 
cuvettes, the absorbance of each solution was determined using a 
U.V./visible double beam spectrophotometer (model 550S, Perkin Elmer 
Ltd., Slough, Berkshire, U.K.).
27 3.5 nm was utilised as the wavelength of maximum absorbance.
A calibration curve was constructed (figure 2.1), using the absorbance 
values obtained for the range of concentrations studied, and this 
indicated compliance with the Beer-Lambert Law. Insulin 
concentrations below 2.85 I.U. cm”  ^ produced very low absorbance 
readings whilst concentrations greater than 22.80 I.U. cm J failed to 
comply with the Beer-Lambert Law. Thus gamma counting (section 
2.2.2) was preferred and used for insulin assay during this study 
unless otherwise stated.
2.2.2. Assay of insulin by a gamma counting method
(a) Outline of technique
Iodine-125 is a radionuclide which disintegrates with the 
emission of gamma radiation. In a gamma counter of the solid 
scintillator type, the gamma rays cause the scintillant (e.g. 
sodium iodide crystals) to fluoresce and by conversion of these 























FIGURE 2.1 CALIBRATION CURVE AND RELATED 
STATISTICAL DATA FOR U.V. 
SPECTROPHOTOMETRIC ASSAY OF 
INSULIN
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decay events occurring in a given period of time.
(b) Insulin assay procedure
The gamma counting technique used for the assay of insulin was 
modified from a method described by Richens [195]. The activity of 
Iodine-125 in test solutions was determined in the following manner:
3 samples, each of 1 cm , were removed from the solution for 
assay using an automatic replicating pipette (Gilson Pipetman P1000, 
Anachem Ltd., Luton, U.K.) and placed into polyethylene sample tubes 
(10 mm x 50 mm, LKB Wallac Oy, Finland). Gamma counting was 
performed using a solid scintillator gamma counter (1275 Minigamma, 
LKB) and was allowed to proceed for 6 00 seconds at the preset Iodine- 
125 energy window. Samples were then returned to the appropriate 
solution.
( c) Background count
The level of background count was periodically monitored by 
determining the gamma emissions of three 1 cm3 samples of distilled 
water over a 6 00 second counting period. A mean value of 2 5+5 
counts per minute (cpm) was obtained and automatically deducted from 
subsequent samples by the gamma counter.
(d) Correcting for radioactive decay
Iodine-125 has a half life (Tl/2) of approximately 6 0 days. The 
number of atoms not yet disintegrated (Nt) at any time t is given by 
equation 2.1 [191].
Nt = Noe”^t (equation 2.1)
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where No is the number of atoms of an isolated radionuclide present 
at time zero.
X is the decay constant, a proportionality factor 
characteristic of the nuclide concerned.
In equal intervals, the number of radioactive atoms decreases by 
the same proportion; the time interval during which the number 
decreases by half is known as the half life:
T 1/2 = ln2 = 0.693 (equation 2.2)
X X
Equation 2.1 may be modified to incorporate the relationship between 
the half life and the decay constant giving equation 2 3.
Nt = No (e -0.6931) (equation 2.3)
T 1/2
Delivery experiments were generally conducted over several days and 
therefore a decay correction using equation 2 3 was necessary.
(e) Calibration curve for Insulin assay by gamma counting
To demonstrate a linear relationship between the relative count 
rate and the relative concentration of insulin in the range to be 
studied (0.029 to 2.850 I.U. cm- )^, successive dilutions of a stock 
solution of Iodine-125 labelled insulin were made. The resulting 
solutions were assayed and results are shown in the form of a 
calibration curve in figure 2.2.
Figure 2.2 and related statistical data showed that there was a 
linear relationship between the count rate obtained from a sample and 
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FIGURE 2.2. CALIBRATION CURVE AND RELATED 
STATISTICAL DATA FOR GAMMA 
COUNTING INSULIN ASSAY
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(n = 3) ranged from 105 to 10453 cpm with coefficients of variation 
not exceeding +2%.
Subsequently, the activity of a labelled solution of known 
unlabelled insulin concentration (2.85 I.U. cm“ )^ was determined for 
each set of experiments and data related to this reference standard.
2.23. Assay of hyoscine methyl chloride by liquid scintillation
counting
(a) Basic principles of liquid scintillation counting
Certain radionuclides such as tritium (3H) spontaneously 
disintegrate with the simultaneous emission of a beta particle 
from the nucleus. This radiation can be measured if the source is 
mixed directly with a scintillator solution, which usually comprises 
solvent, scintillators (or fluors) and other additives. The solvent 
molecules transmit the radiation energy to the scintillators through 
molecular excitation and the fluors in turn re-emit this energy as 
photons of a wavelength detectable by a photomultiplier. However, 
energy transmission between the nuclear particle and the fluor is 
subject to interference from additives, impurities or indeed the 
specimen itself; this energy loss is referred to as ■quenching". It 
is necessary to determine the degree of quenching in each sample and 
correct for it, this is achieved by use of a quench curve.
(b) Quench curve construction
A standard of known activity or disintegrations per minute (dpra) 
is added to the scintillation system and a quenching agent such as
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carbon tetrachloride added in increments. After each addition, the 
sample is counted. From the counts per minutes (cpm) obtained, the 
counting efficiency (the ratio of cpm to dpm) is calculated after 
each addition of quenching agent.
By means of an external standard source, the scintillation 
counter determines the degree of quenching, expresses it as the 
■external standard ratio" or esr and plots a quench curve (esr ' 
versus counting efficiency). A quench curve had been constructed 
previously for the scintillation system (Optiphase Safe) used in the 
present study and was stored in the scintillation counter (figure 
2.3) .
The scintillation counter determines the dpm for an unknown 
sample by measuring the cpm and the esr (or degree of quenching).
Then using the esr and the quench curve, calculates the efficiency 
and thus dpm is obtained.
( c) Scintillation counting assay procedure
The labelling of stock hyoscine methyl chloride solutions was 
achieved by the incorporation therein of tritiated drug solution of 
known activity. Tritium activity in samples for assay was determined 
in the following way:
5 samples, each of 2 00 unr were removed from each solution by means 
of a replicating pipette (Gilson Pipetman P200). The remaining sample
-i
solution was restored to volume by the addition of 1 cmJ of 
appropriate solvent. Each sample was placed into a 5 cnr capacity 
polyethylene mini-vial (LKB) and 4 cnr* of scintillant added by means 
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was capped and the mixture shaken for approximately 5 seconds using a 
"Whirlymixer" (Fisons pic) before being placed into a glass 
scintillation vial (LKB). Samples were counted for 6 0 seconds each, 
with an external standard count time of 3 0 seconds, in an automated 
liquid scintillation system (Rackbeta II 1215 LSC, LKB).
The level of background count was determined for each set of 
experiments by the assay of five 2 00 urn3 samples of distilled water; 
the mean of the counts obtained was subtracted from sample counts 
within that group of experiments.
(d) Reproducibility of liquid scintillation counting technique
A relatively short count time of 60 seconds (compared with a 
normal time of 600 seconds or a minimum of 10,000 counts) was 
employed due to heavy machine usage. The reproducibility of a 60 
second counting time was assessed using the following method.
A serial dilution was made (see section (e) below) from a tritiated 
hyoscine methyl chloride solution of known activity and the resulting 
solutions counted by the method described above. Mean disintegrations 
per minute obtained, ranged from 113 to 1210 dpm with coefficients 
of variation not exceeding + 2.1% (n=5). The coefficient of 
variation in sampling and addition of scintillant were found to be 
+0.6 5% and +0.15% respectively (Appendix 2). The reproducibility of 
the liquid scintillation counting technique was considered to be 
satisfactory for the assay of samples with tritium activity in the 
range investigated using a count time of 60 seconds.
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(e) Construction of calibration curve for hyosclne metbyl chloride 
assay
A solution of known hyoscine methyl chloride concentration 
(2.82 x 10"4 mol dm"3) was labelled with tritiated drug; successive 
dilutions of this mixture were made and the resulting solutions 
assayed by liquid scintillation counting.
The calibration curve (figure 2.4) and relevant statistical data 
for the plot show that there is a linear relationship between tritium 
activity and concentration of hyoscine methyl chloride (in the range 
2.82 x 1CT6 to 2.82 x 10"4 mol dm"3). The liquid scintillation 
counting method was thus considered satisfactory for the assay of 
hyoscine methyl chloride. Subsequently, a reference standard was 
determined for each set of experiments by the counting of a tritiated 
donor hyoscine methyl chloride solution of known concentration 
( section 6 .4 .2 .) .
2.2.4. Propranolol hydrochloride assay by high performance liquid 
chromatography (HPLC)
A HPLC method was developed for the quantitative assay of 
propranolol HC1:
(a) HPLC conditions for propranolol assay
A 15 cm length, 0.5 cm internal diameter (i.d.) stainless steel 
column (HETP, Macclesfield, U.K.) packed with Hypersil 
octadecanylsulphate (ODS) 5 urn reverse phase packing material 
(Shandon Southern Products, Runcorn, U.K.) was maintained in a 















HYOSCINE METHYL CHLORIDE X 104 mol dm 3
SLOPE 2.9 500 x 10
INTERCEPT 0.0008
CORRELATION COEFFICIENT 0.9999
FIGURE 2.4 CALIBRATION CURVE AND RELATED STATISTICAL 
DATA FOR LIQUID SCINTILLATION COUNTING 
ASSAY OF HYOSCINE METHYL CHLORIDE
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The mobile phase comprised:
Tetrabutylammonium hydroxide (40%) 23 cm3
Phosphoric acid
Methanol 500 cm',3
Distilled water to 1000 cm3
The mixture was purged with helium for 15 minutes prior to use, 
giving a solution with a pH of approximately 2.0. A flow rate of 2
Constametric III G, LDC U.K. Ltd., Staffordshire, U.K.), with 
detection at 288 nm by a variable wavelength U.V. detector (Spectro-
delivered by means of a stainless steel loop valve (Rheodyne). A 
peak representing propranolol H d  was observed after approximately 2 
minutes 30 seconds (figure 2.5).
(b) Determination of calibration curve for propranolol HPLC assay
Injections were made (in duplicate) from a series of solutions 
of known concentration in the range 2 x 10“  ^ to 2 x 10”* mol dm”  ^ of 
propranolol HC1 in 50% (v/v) methanol. The height of each peak was 
measured and the mean peak height for each pair of injections 
calculated.
The calibration curve (figure 2.6) and related statistical data 
indicated a linear relationship between peak height and propranolol 
hydrochloride concentration; the assay was therefore considered 
satisfactory.
Variations in HPLC column performance with use are inevitable 
and may manifest as small changes in the calibration slope. Such
cnr min was maintained by a constant metering pump, (LDC
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PROPRANOLOL HYDROCHLORIDE CONCENTRATION 
(x 104 mol dm ^)
SLOPE 8.5185 x 105
INTERCEPT 0.2990
CORRELATION COEFFICIENT 0.9997
FIGURE 2.6 CALIBRATION CURVE AND RELATED
STATISTICAL DATA FOR HPLC ASSAY 
OF PROPRANOLOL HYDROCHLORIDE
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fluctuations were compensated for by the duplicate injection of a 
standard solution of propranolol H &  at the beginning of an assay and 
following every 2 test sample injections (each in duplicate) 
thereafter. In this way the concentration of drug in sample solution 
could be calculated by reference to the standard solution.
2.2.5. Assay of hyoscine hydrobrcmide by HPLC
The method employed was based on a technique described by Yamada 
et al. for the liquid chromatographic assay of belladonna 
alkaloids [197].
(a) HPLC conditions for hyoscine hydrobromide assay
A Hypers 11 ODS column of 15 cm length and 0.5 cm i.d. (HETP) was 
maintained in a water bath at 45+0.1oC. The mobile phase was 
composed of 1-heptane sulphonic acid sodium salt (0.005 mol dm”®) in 
5C% (v/v) methanol. This solution was purged with helium for 15 minutes 
and adjusted to pH 4.0 with glacial acetic acid. A flow rate of 2 
cm-* miri”^ was used (LDC Constametric III G) with detection at 215 nm 
(Spectro Monitor III, LDC/Milton Roy). Injection was by means of a 
50 urn® loop valve and a peak representing hyoscine HBr was 
observed after approximately 3 minutes 20 seconds (figure 2.7).
(b) Calibration curve for hyoscine hydrobrcmide HPLC assay
A calibration curve was constructed (by a method similar to that 
described above m  section 2.2.4.) for hyoscine hydrobromide in the 
concentration range 2.6 x 10”® to 2.6 x 10”® mol dm”®. From 
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HYOSCINE HYDROBROMIDE X 105 mol dm“3
SLOPE 3.8313 x 106
INTERCEPT 0.3616
CORRELATION COEFFICIENT 0.9998
FIGURE 2.8 CALIBRATION CURVE AND RELATED STATISTICAL 
DATA FOR HPLC ASSAY OF HYOSCINE HYDRO­
BROMIDE
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the calibration was judged to be satisfactory.
2.2.6. HPLC of hyoscine methyl chloride
Based on the consideration of the closely related structures of 
the 2 drugs (section 2.1.1), HPLC conditions employed for the assay 
of hyoscine hydrobromide (section 2.2.5.) were investigated for the 
semi-quantitative determination of hyoscine methyl chloride. As 
shown in figure 2.9, a peak was observed approximately 6 minutes 
after injection of hyoscine methyl chloride. Increasing the 
concentration of drug solution injected from 0.7 x 10“  ^ to 1.4 x 10“  ^
mol dm~3 resulted in a doubling of peak height. The above HPLC 
procedure was used to confirm that hyoscine methyl chloride (and not 
a radiolabelled degradant) was being assayed during electrophoretic 
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FIGURE 2.9 HPLC CHROMATOGRAM OF HYOSCINE METHYL CHLORIDE
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PREPARATION OF POLYACRYLAMIDE AND POLYHEMA GELS
3.1. Polyacrylamide gel preparation
The technique used in the preparation of polyacrylamide gels was 
based upon those described by various workers [147,15 0,180] for the 
preparation of gels for analytical and preparative gel 
electrophore sis.
3.1.1. Reagents used in polyacrylamide gel manufacture
Monomers, stock solutions of monomers and catalysts used in gel 
preparation were stored in well-sealed containers, away from light at 
4°C. Acrylamide and N,N'-methylene-bis-acrylamide (Bis) solutions 
were filtered through Whatman No. 4 paper and discarded if unused 
within one month.
Fresh solutions of ammonium persulphate were prepared daily.
3.1.2. Polyacrylamide gel moulds
Glass tubes were utilised as moulds in the preparation of rod­
shaped and disc-shaped gels. These were cleaned by soaking in an 
approximately 3% w/v solution of sodium dichromate in 9C% sulphuric 
acid for 15 to 3 0 minutes followed by thorough rinsing in potable and 
subsequently distilled water. The mould tubes were then oven-dried. 
One end was sealed with a paraffin wax film (Nescofilm, Nippon,
Japan).
Polyacrylamide gel sheets were formed by introducing monomer 
solution into a mould comprising 2 glass plates separated by a 
nitrile rubber spacer.
3.1.3. Degassing of monomer solutions
Evacuation of aerylamide/Bis mixtures proceeded for 15 minutes
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(using a water vacuum) at a pressure of 4 x 10* Pa. The solution was 
then equilibrated at polymerization temperature prior to the addition 
of reaction initiators.
3 .1.4 • Chemically initiated polymerization of polyacrylamide gels
Ammonium persulphate solution and N,N,N'yN'-tetramethylethylene- 
diamine (TEMED) were added, by means of replicating pipettes (Gilson 
Pipetman P100 and P200) in the following quantities to each 10 cm* of 
monomer solution:
Ammonium persulphate solution (0.43 8 mol dm-3) 50 urn3
TEMED (undiluted) 5 um3
The mixture was swirled gently for 8 to 10 cycles, i.e. 
sufficient to mix the initiators completely without the introduction 
of excessive oxygen. The required quantity of monomer solution was 
introduced into the mould chambers using replicating pipettes (Gilson 
Pipetman P1000 and P5000).
The quantities of catalysts, and the degassing time employed 
ensured that visible gelation occurred after 1 5 + 3  minutes; mixtures 
failing to gel between 12 and 18 minutes were discarded. 
Polymerization was allowed to proceed for 30 minutes, gels were then 
inspected for uniformity of polymerization, and stored in buffer 
solution of composition to be employed as electrolyte during 
electrophoresis. Polyacrylamide gels were generally used only after 
several days of storage (to ensure complete polymerization and 
osmotic equilibration with buffer solution) and discarded if unused 
within one month. Buffer solutions were renewed regularly to 
minimise microbial contamination.
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Typical Formula for Polyacrylamide Gel preparation
Acrylamide 13.95 g
Bis ’.i 1.05 g
Ammonium persulphate (0.438 mol dm-3) 250 urn3
TEMED 2 5 um3
Distilled water to 50 cm3
The formula above produced 30T 7C polyacrylamide gels. The 
preparation of 3 types of polyacrylamide gels (rods, discs and 
sheets) is described below:
(a) Preparation of polyacrylamide gel rods
Poly aery lamide gel rods were used in rod gel electrophoresis 
(section 5). In this method, 7.5 cm lengths of glass tubing with an 
internal diameter of 0.5 cm were utilised as gel moulds. 13 cm3 of 
monomer mixture was placed into each tube (this volume consistently 
produced gels of 6 3 cm mean length, with a coefficient of variation 
of less than +2% (n=8)). A layer 0.2 to 0.3 cm thickness of 10%
(v/v) ethanol was carefully layered above the gel solution as quickly 
as possible using a Pasteur pipette. The ethanol layer was used to 
reduce surface tension forces at the top of the gel solution so as to 
produce a flat gel surface and also protect the monomer mixture from 
atmospheric oxygen which can give rise to an uneven surface (through 
inhibition of polymerization). Polymerization was allowed to proceed 
at room temperature? a sharp boundary was observed at the gel/overlay 
interface when visible gelation had occurred. The gels were flushed 
with and stored in buffer until use.
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(b) Preparation of polyacrylamide gel discs
Polyacrylamide gel discs retained within glass moulds were used 
mainly in electrophoretic release studies described in section 6.
To form gel discs, 3 cm^ of gel solution was introduced into glass 
cylinders of 1.9 cm i.d. and 1.0 cm length. This volume of monomer 
mixture just overfilled the mould chamber giving a dome shape to the 
liquid surface. Consequently a flat gel surface resulted without the 
necessity for overlaying. Polymerization was allowed to proceed in a 
waterbath at 10°C, higher temperatures resulting in the separation of 
the gel from the chamber wall (section 1.5.4.1.).
(c) Preparation of polyacrylamide gel sheets
Sheets of polyacrylamide gel were formed by pouring 
approximately 10 cm^ of monomer solution into a mould comprising 2 
glass plates (8 cm x 16 cm) separated (by 1.5 mm) by a nit rile rubber 
spacer. The polymerization was performed in a waterbath at 10°C, the 
gel sheet was then removed from the mould and rinsed in distilled 
water before storage. Polyacrylamide gel sheets were used for 
permeation experiments (section 4.4.2.) and to study the effect of 
gel thickness upon electrophoretic drug release (section 6.4.2.2.e.).
3 .2 . Chemically initiated polymerization of polyHEMA gels
PolyHEMA gel preparation procedure was based on the chemical 
catalyst system used in polyacrylamide gel manufacture (section 
3.1.4) and a technique reported by Wood et al. [19 8] for the 
polymerization of polyHEMA gels.
PolyHEMA gels (10 to 80T) were prepared from 2-hydroxyethyl 
methacry late (HEMA) monomer and also by co-polymerization with a
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crosslinking agent (0.5C), ethylene glycol dimethacrylate (EGDMA) 
monomer. HEMA and EGDMA were stored at 4°C and away from light. 
Monomer solutions were degassed (3.1.3.) before the addition of 1 cm3 
of freshly prepared ammonium persulphate solution (1 mol dm-3) 
producing 50 cm3 of gel mixture. After introducing gel mixture into 
rod gel moulds (3.I.2.), rubber closures were used to seal moulds and 
protect the reaction mixture from atmospheric oxygen. Polymerization 
was allowed to proceed in a 50°C water bath for 18 hours. The 
polyHEMA gels formed were rinsed with and stored in buffer solution.
3.3. Polymerization of polyacrylamide and polyHEMA gels by gamma- 
irradiation
Wood et al. [198] preferred the use of gamma irradiation to 
initiate polymerization of hydrogels and avoid gel properties 
associated with residual materials following chemically initiated 
polymer iza tion.
3.3.1 Gamma radiation source dosimetry
Before polymerization was attempted, the dose rate of the gamma 
source (Caesium - 137) was measured using the Fricke dosimetry system 
as described by Ahmed [199]. In this technique, gamma radiation 
causes the conversion of iron (II) ions to iron (III) ions. The 
oxidation reaction may be quantitatively followed by U.V. 
spectrophotometric assay, thus a direct measure of energy absorbed by 
the dosimetry solution due to ionizing radiation is obtained.
Dosimetry solution was introduced into rod gel tubes and these 
were placed at a height of 40 cm in the gamma source apparatus.
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After 3 0 minutes of exposure to the radionuclide, dosimetry solutions 
were assayed in lcnr quartz curvettes at 3 05 nm using a single beam 
spectrophotometer (Unicam SP5 00). A gamma dose rate of 5.5 J Kg”  ^
min”  ^was obtained.
3.3.2. Gamma-irradiation initiated polymerization
Monomer solutions of various formulations were purged with helium 
for 15 minutes prior to degassing (section 3.1.3) and introduced into 
rod gel tubes. After sealing with rubber closures, the tubes were 
subjected to gamma irradiation at ambient temperature for 18 hours.
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3 .4 Results and discussion
(i) Chemically initiated polymerization
Polyacrylamide gels for PAGE are normally of monomer 
concentration in the range 3 to 30T (section 1.5.4.1.). In the present 
study, polyacrylamide gel rods (5 to 3 0T) and gel discs in the range 10 
to 30T were manufactured with relative ease. However, heat generation 
during polymerization which has been found previously with large 
diameter gels and those of high monomer concentration [150] 
occasionajly caused some irregularities in 4 0T polyacrylamide discs. 
Voids and separation of gel from the mould wall was frequently 
observed in 50T gel discs, despite the use of low polymerization 
temperatures (10°C).
It was considered that the improved dissipation of heat from 
polyacrylamide gel sheets during their polymerization was responsible 
for the high gel monomer concentrations attained (10 to 80T); although 
polymerized at 10°C, it was found that gel sheets could also be 
prepared at room temperature. PolyHEMA gels of 5 0T and of "lower 
monomer concentration appeared white, whilst 60T, 70T and 80T 
polyHEMA gels were transparent but often contained numerous voids and 
showed separation from the mould walls. PolyHEMA gel turbidity 
arises because the polymerization of a solution containing less than 
5 8% monomer causes the solvation capacity of the resulting polymer to 
be exceeded, and microsyneresis (phase separation) occurs [7].
(11) Gamma-irradiation polymerization
Polyacrylamide and polyHEMA gel rods of an acceptable quality 
(e.g. uniform appearance) could not be prepared using the methods 
described in section 3.3. This was believed to be due to a number
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of factors: (1) long polymerization times I.e. 18 hours compared
with 15 minutes for polyacrylamide gels by chemically initiated 
polymerization (section 3.1.4). (2) Uneven dose rate along length
of gel rod due to gamma source geometry. (3) Lack of temperature 
control during polymerization. (4) Inadequate maintenance of monomer 
de-aeration due to long polymerization times.
Chemically initiated polymerization was therefore used to 
prepare polyacrylamide gels for the remainder of this study.
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CHARACTERIZATION OF POLYACRYLAMIDE GELS
4. Characterization of polyacrylamide gels
Some properties of polyacrylamide gels, regarded as likely to 
influence their functioning as materials employed in electrophoretic 
drug release studies, were assessed.
4.1. Appearance and texture of polyacrylamide gels 
Assessment of polyacrylamide gel appearance and texture is
discussed in section 4.6.
4.2. Scanning electron microscopy of polyacrylamide gels
Despite the wide use of polyacrylamide gels in electrophoresis, 
little work has been carried out to investigate the structure of the 
sieving gel. Scanning electron microscopy has found application 
[170,171], whilst more recently, workers have utilised transmission 
electron microscopy to view polyacrylamide gels [172].
In the present investigation, polyacrylamide gel structure was 
examined in a scanning electron microscope (JEOL JSM 35C, Japanese 
Electron Optics Ltd., Japan).
Gels were cut into strips and rapidly frozen by immersion in 
liquid nitrogen. Using forceps, frozen gels were removed and 
fractured by striking with a hammer before being replaced into the 
liquid nitrogen. Freeze-fractured gels were then freeze-dried at 
-6 0°C (Edwards-Pearse Tissue Dryer EPD3, Edwards High Vacuum,
Crawley, Sussex, U.K.) for between 8 and 16 hours.
Gel samples were mounted in graphite colloid on 2i cm diameter 
planchettes. A layer of gold was deposited onto the gel surface by 
means of a sputter coater (Edwards S15QB, Edwards High Vacuum). Gels 
were scanned at an electron beam energy of 20 kV, the gold and
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graphite layers ensuring conductance of the sample. Unless viewed 
immediately after sputtering, samples were stored over dried silica 
gel in a sealed container to avoid cracking of the gold layer caused 
by atmospheric humidity changes.
4.3 • Swelling behaviour of polyacrylamide gels
Polyacrylamide gel discs were prepared as described in section 
3 .1.4 .b. and unless otherwise stated were removed from moulds before 
use.
Before weighing, gels were rinsed with fresh immersing solution 
and blotted with tissue to remove superficial liquid. Approximately 
30 minutes after visible gelation, gel discs were weighed (initial
3
gel weight) and placed into a beaker containing approximately 50 cm 
of the appropriate soaking solution which was maintained at 3 0+0.1°C 
in a water bath. Polyacrylamide gel discs were removed at regular 
intervals for weighing, and soaking solutions were changed dally to 
minimise bacterial infestation and interference from substances 
leached from the gel (section 4.5.). The degree of swelling was 
estimated from the observed change in gel weight using equation 4.1.
Wt-Wo x lOCfe (equation 4 .1)
Wo
where Wt was the weight of polyacrylamide gel at time t and 
Wo was the ini tied, gel weight
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Figure 4.1 illustrates the degree of swelling with time of 40T 7C 
polyacrylamide gels immersed in 0.04M citrate-phosphate buffer 
(intended for use in electrophoretic release experiments, section
6.4.1.), pH 3.0 and represents a typical gel weight change profile; a 
qua si equilibrium for swelling was reached after approximately 100 
hours. Subsequent data (figures 4.6 to 4.9) show the percentage 
weight increase of gels after 120 hours, although most determinations 
were allowed to proceed for a minimum of 200 hours to ensure that 
equilibrium swelling had been attained. Unless stated to the 
contrary, each data point (figure 4.1 and figures 4.6 to 4.9 
represents the mean of 3 determinations with vertical bars indicating 
standard deviation about the mean.
4.3.1. Factors affecting polyacrylamide gel swelling
(a) Ionic strength of Immersing solution
30T 7C polyacrylamide gel discs were soaked in distilled water 
(pH c-5) and Mcllvane's citrate-phosphate buffer of 0.04 M, 0.08 M, and 
0.12M ionic strengths (in the pH range 2.9 to 3 .0).
(b) Polyacrylamide gel formulation
Polyacrylamide gel discs in the range 10 to 50T (7C) were 
prepared and immersed either in distilled water, or in 0.04 M 
Mcllvane's citrate-phosphate buffer, pH 3.0.
Polyacrylamide gels, crosslinked in the range 2 to 3 0% (C) with 
bisacrylamide (Bis) at a constant 30% total monomer (T) were prepared 





























FIGURE 4.1 SWELLING OF 40T 7C POLYACRYLAMIDE 
GEL IN 0.04M CITRATE-PHOSPHATE 
BUFFER (pH 3.0)
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( c) Polyacrylamide gel polymerization temperature
Polyacrylamide gels (40T 7C) were prepared by allowing 
chemically initiated polymerization to proceed at the following 
initial temperatures: 10, 20 and 30°C. The temperature change in the 
gel mixture during the course of polymerization was not monitored.
The swelling behaviour of the polyacrylamide gels formed was 
investigated by immersion in 0.04M citrate-phosphate buffer, pH 3.0.
(d) Polyacrylamide gel swelling during electrophoresis
Polyacrylamide gel discs (retained within glass moulds) were 
stored for 3 weeks in either distilled water or 0.04 M citrate- 
phosphate buffer, pH 3.0; both solutions were renewed regularly. The 
gel discs were then placed into 2-compartment electrophoretic release 
apparatus (section 6.1 and figure 6.1) and subjected to pre-
3
electrophoresis at a constant 3 0 volts (see section 6.2.). 17 5 cm
of electrolyte solution (of identical composition to gel storage 
solutions) was used in each chamber and the apparatus maintained at 
3 0+0.1 °C in a waterbath. At timed intervals, the apparatus was 
dismantled and the gel disc (and glass mould) blotted dry with tissue 
prior to weighing. After reassembling the apparatus, electrolyte 
solution was returned to the appropriate compartments and pre­
electrophoresis continued. After the last weighing, the 
polyacrylamide gel was removed from the glass mould and the latter 
weighed to determine the gel weight.
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4 .4. Drug partitioning and permeation in polyacrylamide gels
The permeability coeffient, P, of a solute in a polymer membrane 
may be expressed as the product of its diffusion coefficient, D, and 
its distribution (partition) coef^.cient, Kd, in the polymer (equation 
4.2 [73]).
P = DKd (equation 4.2)
The permeability in hydrogels of solutes of both high and low 
molecular weights has been widely studied [105-108,2 00,2 01],
The techniques employed therein formed the basis of methods utilised 
in the current investigation.
The distribution coefficients and permeabilities of insulin, 
hyoscine hydrobromide, propranolol hydrochloride and hyoscine methyl 
chloride in a number of polyacrylamide gel formulations were 
determined (section 4.4.1). Polyacrylamide gel sheets prepared by 
the method described previously in section 3.1.4.c. were used.
4.4.1. Determination of drug distribution coefficients (Kd) in 
polyacrylamide gels
Kd is defined as the ratio of the concentration of solute in the 
gel phase and solute concentration in the surrounding solution phase, 
and was determined using a "solution depletion” method described ny 
Lee et al. [201].
Strips of polyacrylamide gel (approximately 0.15 cm x 1 cm x 
4 cm) were stored in drug-free buffer solutions for 1 to 2 weeks 
before Kd determinations. After removal, strips were rinsed with 
fresh buffer solution and blotted dry with tissue before being placed 
into 10 cm^ of drug solution in a glass vessel. Drug concentrations
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and buffer solutions were as described in electrophoretic release 
experiments (section 6). The soaking vessels were shielded from 
light and shaken gently in a waterbath at 3 0°C for at least 2 4 hours. 
The drug content of the solutions surrounding the gels was determined 
by assays described in section 2.2. The volume of soaked gels was 
calculated from gel dimensions, the thickness being measured with a 
micrometer after placing the gel sample between 2 perspex plates of 
known thickness. The distribution coefficient was calculated using 
equation 4.3 [201].
Kd = (Cs-Cs) Vs (equation 4 .3 )
Cs Vm
o
where Cs is the initial drug solution concentration 
s
Cs is the concentration of solution surrounding the 
gel after equilibrium
o
Vs is the initial solution volume
Vm is the volume of the swollen gel.
Each determination was performed in triplicate.
The values obtained for Kd using the above technique were found 
to be highly variable. Increasing the soaking time in increments, 
up to one week, and varying the solution to gel volume ratio 
between 25 and 14 0 did not improve the reproducibility of the 
procedure (see section 4.6).
4.4.2. Drug permeation in polyacrylamide gels
The diffusive permeation of insulin, hyoscine hydrobromide,
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hyoscine methyl chloride and propranolol hydrochloride was determined 
using an apparatus comprising two chambers of equal volume (as 
described below in section 6.1. and figure 6.1). A polyacrylamide 
gel membrane of approximately 1.5 mm thickness was supported by a 
rubber 'O' ring and held between the 2 compartments (donor and 
receptor) which were clamped together tightly without causing 
excessive squeezing of the gel, to provide an exposed membrane area 
of 4.0 cm2. 175 cm3 of the drug solution of interest (i.e. donor 
concentrations employed in section 6.) was placed into the donor 
compartment whilst the same volume of the appropriate drug-free 
buffer was introduced into the receptor. To reduce boundary layer 
effects, solutions were stirred at 24 0 r.p.m. by PTFE paddles; 
insulin solutions were stirred at a slower speed of 12 0 r.p.m. to 
minimise solution frothing. The permeation apparatus was placed into 
a waterbath maintained at 3 0+0.1°C and samples removed from the 
receptor compartment at timed intervals for assay. Where sample 
solutions were not returned, the receptor volume was restored by the 
addition of drug-free solution and the mass of solute removed 
corrected for when calculating the permeation data.
Each permeation study was performed in duplicate. To illustrate 
a typical permeation profile, figure 4.2 shows the percentage fraction 
of hyoscine methyl chloride permeating with time. The lag time is 
obtained from this type of curve by extropolation of the steady state 
portion to the time axis (section 1.2-4.3.). From the slope of the 
straight line region, the permeability coefficient, P, may be 
calculated using equation 4.4, previously used by Beal to assess the 





































FIGURE 4. 2 HYOSCINE METHYL CHLORIDE PERMEATION 





P A CD (equation 4 .4 )
dt 1 VR
S
where CR is the receptor solution concentration 
s
CD is the donor solution concentration 
VR is the volume of the receptor solution 
1 is the membrane thickness 
P is the permeability coefficient 
A is the membrane area
4w4J2.1. Effect of gel formulation on the permeability of drugs in 
polyacrylamide
The effect of increasing gel density in the range 10T to 50T 
upon the permeability of several drugs through polyacrylamide gels 
crosslinked to the same extent (7C) was studied. The influence of 
crosslinking (in the range 4 to IOC) upon permeability of insulin and 
propranolol hydrochloride was investigated using gels of 3 0% total 
monomer concentration (T).
4.5. Chemical Impurities in polyacrylamide gels
The presence of unreacted catalysts, monomers and other 
chemicals within polyacrylamide gels may be detrimental to their 
subsequent performance during electrophoresis. For this reason, 
purification of gels has been attempted by pre-electrophoresis [202] 
and by incubation in buffer solution prior to electrophoresis [203], 
both procedures apparently extracting U.V. absorbing material. In
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this study, the U.V. absorbances of solutions in contact with 
polyacrylamide gels, undergoing incubation were monitored.
4.5.1. U.V. absorbance characteristics of reagents used in
polyacrylamide gel preparation
The absorbance maxima of solutions of polymerization reagents in 
citrate-phosphate buffer, pH 3.0 were determined using a double beam 
spectrophotometer (Perkin Elmer, 550S):
Acrylamide 195 nm
Bis 195 nm
Ammonium persulphate 195 nm
TEMED 205 nm, 254 nm, 259 nm, 265 nm.
4.5.2. Removal of gel impurities by Incubation in buffer solution 
3 0 minutes after visible gelation, a 40T 7C polyacrylamide gel
disc was suspended by means of a PTFE basket in a jacketed vessel 
containing 175 cm^ of 0.04M citrate-phosphate buffer at pH 3.0. The 
buffer solution was stirred by a PTFE-coated magnetic bar and 
maintained at constant temperature by the continuous circulation of 
water from a bath at 30°C through the vessel jacket. The apparatus 
was protected from light and the absorbance of the buffer solution in 
the range 185 to 300 nm determined at timed intervals using a double 
beam scanning U.V. spectrophotometer. Where absorbance readings were 
greater than 1.0, sample solutions were diluted accordingly. The 
incubating buffer was replaced with fresh solution after each 
absorbance reading.
102
4 .6 Results and discussion
( i) Appearance and texture of polyacrylamide gels
Polyacrylamide gels were generally transparent and of rubber­
like consistency; increasing monomer concentration caused them to 
become more brittle and rigid. An improvement in mechanical strength 
was observed with increased crosslinking (Bis) up to approximately 
7C; crosslinking to a greater extent resulted in increasingly opaque 
gels of poor mechanical strength. Turbidity was also observed in 
gels polymerized at less than 10°C. Opacity in gels polymerized 
using low initiator concentrations and temperatures has been reported 
previously [147,16 8].
Polyaerylamide gels became increasingly opaque as crosslinking 
was increased above 7C, 15C gels appeared white. This phenomenon is 
discussed below in section 4.6.iii.
(ii) Electron microscopy of polyacrylamide gels
Electron micrographs shown in figures 4.3 to 4.5 illustrate the 
cellular construction of polyacrylamide gels of various formulations. 
A 5T 5C polyacrylamide gel such as used in rod gel electrophoresis 
(section 5) appears to have walls with thicknesses in the micrometer 
range, enclosing pores of 10 to 3 0 urn diameter (figure 4 3.a.). 
Increasing gel concentration to 20T (5C) is seen to reduce pore size 
to generally less than 10 micrometers (figure 4J.b.); heterogeneity 
in structure was commonly observed during electron microscopy studies 
of polyacrylamide gels. 20T 5C gels viewed at higher magnification 
(X43 00) yielded no further information about the pore structure 
(figure 4.3 .c.).
Figures 4.4.a. to 4w4.f. show the effect on polyacrylamide
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FIGURE 4.3.a 
ELECTRON MICROGRAPH OF 5T 5C 
POLYACRYLAMIDE GEL
FIGURE 4.3.b.
ELECTRON MICROGRAPH OF 20T 5C 
POLYACRYLAMIDE GEL
FIGURE 4.3.C.
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FIGURE 4.4.e. FIGURE 4.4.f.
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structure of increasing total gel monomer concentration in the range 
10 to 60T (7C). A general increase in the concentration of mass per 
unit area is apparent in going from 10 to 60T; however an increase in 
wall thickness reported by Blank and Reimschuessel [170] with 
increased monomer concentraton was not found in this study. Cellular 
structure was difficult to make out in 60T polyacrylamide gels 
(figure 4.4 .f.) even at higher magnification.
The influence on gel structure of crosslinking 30T 
polyacrylamide gel in the range 2 to IOC with Bis is shown in figures
4.5.a. to 4.5.f. Pores surrounded by clusters have been observed in 
IOC gels of lower (10T) total monomer concentration [17 0], clusters 
were not observed during this study.
It is considered that some wall thickening may occur when Bis is 
increased from 2 to 4C; subsequently, pore size becomes reduced (6,7 
and 8C) with a slight increase in going from 8C to IOC.
The difficulty of interpreting electron microscopy data is 
highlighted by figure 4.5.d. where 7% crosslinked polyacrylamide gel 
appears to have a more open pore structure than 6C or 8C gels 
(figures 4.5.c. and 4.5.e.). Thus information derived from this 
technique is of limited usefulness since intrasample variation often 
exceeds that found between different gels. Sampling and sizing in a 
statistically valid and methodical manner may be a more appropriate 
technique to quantitatively study polyacrylamide gel structure by 
electron microscopy.
Nevertheless, some points are apparent from scanning electron 
microscopy of polyacrylamide gels. The cellular structures observed 
during this study, having diameters in the micron size range would
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not produce a direct sieving action, even on macromolecules. The 
substructure o£ the surrounding walls is likely to be the source of 
molecular sieving found in these gels and will depend on the pores 
not being interconnected (section 1.5.4.1,2)this is in agreement with 
the hypothesis made by Calvert [173].
A cellular structure in the sub-micron range has been revealed 
by transmission electron microscopy of polyacrylamide gels [172].
( iii) Swelling behaviour of polyacrylamide gels
(a) Ionic strength of immersing solution
Figure 4.6 indicates that the extent of polyacrylamide gel 
swelling increases with citrate-phosphate buffer ionic strength.
Morris and Morris [163] also found that swelling of polyacrylamide 
gels was dependent upon buffer concentration. With gels carrying 
ionic groups (e.g. polyHEMA), the effect of ionic solutions are 
readily understood and have been well studied [7], However, simple 
polyacrylamide gels are generally regarded as having no ionizable 
groups. A factor that may have potential effect is the affinity of 
the solute for the gel phase compared with that for the aqueous phase 
(partition coefficient). Boyde [17 4] studied the effect of pH (4-10) 
on hydrogel swelling and found gross polyacrylamide gel swelling at pH 
9 and above.
(b) Polyacrylamide gel formulation
From figure 4.7, it can be seen that the degree of 
polyacrylamide gel swelling in both distilled water and citrate- 
phosphate buffer increased as total monomer concentration (T) 
increased; gels incubated in buffer showing a greater degree of
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swelling in all cases.
The above results are similar to those obtained by White and 
Dorion [204] who studied polyacrylamide gels in the range 5-50T and 
found that 5T and 10T gels showed almost identical swelling curves; 
Richards and Lecanidou [17 5] found a minimum of swelling at 9-15T.
The greater concentration of polyacrylamide chains which have a 
tendency to become solvated (thus causing expansion of the hydrogel 
network) are probably responsible for the greater degree of swelling 
observed with increased total monomer concentration.
The degree of swelling in 30T polyacrylamide gels shows a marked 
fall (figure 4.8) between 2C and IOC. The extent of swelling is 
believed to be reduced by increasing C due to the reduced 
"contractility' of the gel network. 15C and 20C gels appeared to 
swell to a similar extent. This data shows good agreement with that 
predicted by Richards and Temple [176], Hsu [16 8] suggests that 
above 10Cr any additional Bis should, in an ideal crosslinked 
network increase crosslinking density but, in reality, forms clusters 
which leads to gel inhomogeneity. Richards and Temple [17 6] agree 
that increased local polymer concentration may lead to raicro- 
syneresis (or phase separation) which accounts for polyacrylamide gel 
opacity at high crosslinking concentrations.
(c) Effect of polymerization temperature
Increasing the initial polymerization temperature from 10 to 
30°C appears to increase the extent of polyacrylamide gel swelling 
(figure 4.9) but the relationship is not well defined. Gels 





















FIGURE 4.8 EFFECT OF CROSSLINKING ON SWELLING
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increased polymer "clustering" (see above) at lower polymerization 
temperatures leads to a decrease in effective crosslinking therefore 
reducing the capacity to swell.
(d) Swelling during electrophoresis
Electrophoresis does not appear to cause gel swelling to any 
marked extent; figure 4.10 shows that approximately a 1.5% gel weight 
increase is seen after 50 hours of electrophoresis using distilled 
water or citrate-phosphate buffer as electrolyte. The mechanism of 
any swelling caused by electrophoresis is unclear, although it is 
considered that electrolysis products may be involved.
On the basis of the results of polyacrylamide gel swelling 
studies, it was considered that gels should be stored in appropriate
5
solution^for several days before use in electrophoretic release 
experiments so. that equilibrium swelling was attained.
(iv) Drug permeation and partitioning in polyacrylamide gels
The difficulties encountered in trying to obtain drug partition 
coefficients in polyacrylamide gels are not easy to explain.
It is possible that microbial contamination may have caused 
interference. Buffer solutions were used in this study to simulate 
conditions during electrophoretic release studies, it is considered 
that the use of drug solutions in distilled water to immerse 
polyacrylamide gels for partition studies may yield more reproducible 
data.
From figure 4.11 it can be seen that drug permeabilities 
decreased with increasing polyacrylamide gel concentration. This is 
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network as T is increased. Relative permeabilities increased with 
decreasing (ionized) solute molecular weight in the order: 
insulin < hyoscine methyl chloride < hyoscine hydrobromide < 
propranolol hydrochloride. An exception was permeation in 50T 
polyacrylamide gels where hyoscine methyl chloride showed a greater 
permeation rate than hyoscine hydrobromide. This data suggests that 
the above solutes migrated through the polyacrylamide gels tested via 
a "pore" mechanism which is dependent upon solute molecular volume 
and pore size of the polymer membrane [82].
Permeation of these solutes through higher polymer 
concentrations may occur by the "partition* mechanism (section 
1.4.1.4.) e.g. as found by Wood et aL [107] who studied the diffusion 
of salicylic acid in polyHEMA gels.
Increasing the concentration of Bis was found to cause a 
reduction in the permeability of propranolol hydrochloride and 
insulin through polyacrylamide gels up to a crosslinking value of 7 
to 8C (figure 4.12). (From gel chromatography experiments, Fawcett 
and Morris [205] found that at any given value of T, the permeability 
of proteins in polyacrylamide gels showed a minimum at about 5C).
Above this concentration of crosslinker, permeation of both molecules 
was found to increase.
Increased solute diffusion rates through hydrogels of increasing 
crosslinking concentration have been reported [85,201] and were 
believed to be due to the increasing dominance of the "partition" 
mechanism over pore transport resulting from pore size reduction 
caused by increased crosslinking. Insulin is believed to diffuse by 
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[80]. In the present study which used highly hydrated (at least 5C%) 
gels, the "pore" mechanism is considered to dominate at the 
crosslinker concentrations studied.
An increase in pore size is believed to account for increased 
solute permeability in polyacrylamide gels containing more than 7-8% 
crosslinker; a postulation supported by the results of electron 
microscopy of polyacrylamide gels (section 4.2.). However, in the 
absence of partition data, the possibility of drug transport through 
polyacrylamide gels by the partition mechanism cannot be excluded.
On the basis of drug permeability coefficients obtained from the 
above study, the fraction of drug likely to permeate in 4 days 
through 10 mm thickness 19mm diameter polyacrylamide gels during 2- 
compartmental electrophoretic release studies was calculated using 
equation 4.4. It was found that less than 0.3% of the original donor 
concentration of insulin would be expected to permeate into the 
receptor through 3 0T 7C polyacrylamide gel whilst less than 0.7% of 
hyoscine methyl chloride, hyoscine hydrobromide and propranolol 
hydrochloride would permeate through 4 0T 7C polyacrylamide gel 
during (a normal run time of) 4 days.
(v) The removal of chemical impurities from polyacrylamide gel 
by incubation in buffer
The wavelength of maximum absorbance of the incubating solution 
was found to occur at 195 nm.
Figure 4.13 indicates that cumulative absorbance of the incubating 
buffer increased rapidly in the first 1-2 days of immersion followed 
by a steadily declining rate of increase thereafter. The nature of 







































FIGURE 4.13 INCREASE IN UV ABSORBANCE OF A 
SOLUTION USED TO INCUBATE 40T 
7C POLYACRYLAMIDE GEL
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absorbance maxima of the incubating solution (195 nm) was believed to 
be a mixture of unreacted monomers and catalysts used in gel 
polymerization. U.V. absorbing material has also been extracted from 
polyacrylamide gels by Loening [206] using a similar technique.
On the basis of results obtained in the above study, 
polyacrylamide gels were usually used only after several days of 
storage in buffer to ensure removal of most U.V. absorbing material.
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ROD GEL ELE CTROPHORESIS
5. Rod gel electrophoresis
The technique used in rod gel electrophoresis was based on 
widely described methods for zone polyacrylamide gel electrophoresis 
(section 1.5.4.)/ although voltages used for electrophoresis were 
generally much lower than usually employed in PAGE (section 
1.5 .4 .4 .) .
5.1. Electrophoresis apparatus
Rod gel electrophoresis was performed using 2 types of 
apparatus: a commercial system (Model GE4, Pharmacia Fine Chemicals, 
Sweden) and a specially constructed device (figure 5.1). Both pieces 
of apparatus consisted of upper and lower electrolyte chambers of 0.5 
and 1.5 dm3 capacity respectively. 2 rows of 4 gel rod tubes were 
held precisely vertical in rubber grommets mounted in the base of the 
upper compartment in such a way that the gel within them connected 
the electrolyte reservoirs. Electrodes of platinum wire were located 
on the upper and lower edges of a central ridge in the upper vessel.
Stabilised power supplies generating constant voltages between 0 
and 30 volts at 0 to 1 amp (E3 0/1, Farnell Instruments Ltd.,
Wetherby, Yorks) and 0 to 300 volts (EP3, Millipore) were used in 
conjunction with a multimeter to generate appropriate electric fields 
within the apparatus.
5.2. General technique of rod gel electrophoresis
5T 5C polyacrylamide rod gels (section 3.1.4.a.) were used 
unless otherwise stated. 0.5 dm3 and 1.5 dm3 of 0.025M Sorensen’s 
phosphate buffer pH 7.4 was placed into the upper and lower 











FIGURE 5.1 APPARATUS FOR ROD GEL ELECTROPHORESIS
level of electrolyte in the upper compartment) in a waterbath at 
3 0+0.1°C. Pre-electrophoresis was performed at the proposed running 
voltage for 1 hour in an attempt to remove ammonium persulphate and 
other gel impurities.
A 50 umJ sample of f luores cam ine-label led (Appendix 1) protein 
solution (equivalent to approximately 5 x 10”  ^ g of protein) was 
carefully applied, by means of a replicating pipette (Gilson Pipetman 
P100), to the surface of each gel. The inclusion of glycerol (10% 
v/v) in the protein solution increased the density of the mixture and 
minimised dispersion of the sample after application.
Electrophoresis was commenced as soon as possible; the voltage 
and current were measured at the start and completion of each run.
By use of a transparent water bath, the fluorescent protein bands 
could be observed migrating downwards. For each set of experiments, 
a run time was chosen to give sample migration distances to points 
approximately 1 to 2 cm from the bottom of each gel. Unless 
otherwise stated, a constant potential difference of 3 0 volts was 
applied. After termination of electrophoresis, gel tubes were 
removed from the apparatus and band migration distances accurately 
measured. Gels were examined against a black background using an 
ultraviolet light source to aid visualization of the f luores cam ine- 
labelled proteins.
Protein band migration velocities were determined by dividing 
migration distance by electrophoresis time. 4 rod gels were used for 
each determination (figures 5.2, 5.3, 5.5 and 5.9 to 5.12) which was 
performed in triplicate; data points represent the mean of 3 determin­
ations with vertical bars indicating standard deviation about the mean.
125
5.2.1. Factors affecting the electrophoretic migration velocity of
proteins in polyacrylamide rod gel electrophoresis
(a) Applied potential difference
Voltages in the range 2 to 250 volts (0.2 to 35.0 mA) were 
employed to induce electric fields within the rod gel apparatus. This 
involved the use of 2 power supplies (0-3OV and 0-300V). To assess 
the influence of using 2 different sources, experiments performed at 
3 0 volts were repeated using both supplies. From the reproducibility of 
protein migration velocities obtained (figure 5.2), the procedure of 
utilising a more powerful, second power supply, for potential 
differences of 3 0V and above was considered satisfactory.
(b) Electric current
Currents in the range 0.2 to 35.0 mA (2 to 250 volts) were 
produced using two power sources. The validity of this method was 
assessed by a technique similar to that described above in section
5.2.1.a. and considered to be satisfactory. The current was found to 
fluctuate (usually decreasing during electrophoresis) e.g. from 0.2 9 
to 0.26 mA and from 32 to 31 mA). The mean current was determined 
from readings obtained at the beginning and end of each run. The 
current per gel was obtained by dividing the mean current by the 
number of gels (usually 8) used in the rod gel apparatus.
(c) Electrophoresis temperature
The influence of temperature upon the migration velocity of 
insulin-F was determined by performing electrophoresis (at 3 0V) using 
temperatures in the range 15 to 50°C. For temperatures of 25°C and 
below, a cooling unit was necessary to maintain constant temperature
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conditions. Changes in buffer pH were observed over the temperature 
range under study and where necessary, phosphoric acid or sodium 
hydroxide (1M) was added to adjust the buffer pH to 7.4.
(d) Electrolyte ionic strength
Sorensen's phosphate buffer was prepared and diluted to 
give solutions of ionic strengths in the range 0.001M to 0.5 M. Where 
necessary, solutions were adjusted to pH 7.4 as described above in section
5.2.I.e. The influence of electrolyte ionic strength on the 
migration velocities of BSA-F and insulin-F was assessed by 
performing electrophoresis at a constant 3 0 volts.
(e) The effect of electrolyte pH
Mcllvane's citrate-phosphate buffer in the pH range 3 to 8 
was prepared. • Potassium chloride was added to each solution as 
described by Elving et al. [207] producing buffers of constant ionic 
strength (0.5M). The attachment of fluorescamine (appendix 1) at 
amino groups interferes with the ability of a protein to act as a 
zwitterion. Thus to determine the influence of pH upon bovine serum 
albumin (BSA) and insulin electrophoretic migration, unlabelled 
proteins were utilised. These were visualised, subsequent to 
electrophoresis by a staining/destaining technique [208]:
1) Gels were removed from glass tubes by injection of water 
between gel and tube wall.
2) Each gel was placed into a test tube and •fixed’ using a 
mixture comprising methanol: acetic acid: distilled water 
(5:1:5) for 1 hour.
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3) Staining was allowed to proceed for 45 minutes in a protein 
stain, Coomasie Brilliant Blue R, dissolved in fixing 
solution to produce a 0.1% w/v solution.
4) Gel destaining, using a methanol: acetic acid: water (2:3:35) 
mixture was continued until protein bands were clearly visible 
in otherwise transparent gels (usually 30 to 60 minutes).
( f) Percentage total monomer (%T) In gel
Polyacrylamide rods in the concentration range 5 to 25% total 
monomer (T) 5% crosslinked (C) with Bis were used.
(g) Extent of crosslinking (C) in gel
5T polyacrylamide rods crosslinkeci to varying extents (2 to 3 0C) 
with Bis were used in this study.
5 .2 .2• FolyHEMA rod gel electrophoresis
This was performed using polyHEMA gels prepared by chemically 
initiated polymerization. 6 0, 7 0 and 80T gels, either crosslinked 
with EGDMA (0.5C) or uncrosslinked were employed. The rod gel 
electrophoresis apparatus and technique described in sections 5.1. 
and 5.2. were utilised for the study of BSA-F and insulin-F migration 
behaviour.
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5 .3 Results and discussion 
( i) Polyacrylamide rod gel electrophoresis 
(a-b) Applied potential gradient and current
Protein sample bands obtained during rod PAGE were usually 1 to 
2 mm in thickness. Occasionally, a fainter second band was observed; 
this was considered to be due to the presence of protein dimers.
Figures 5.2 and 5.3 show the effect of varying applied voltage 
and current respectively upon the electrophoretic migration of BSA-F
and insulin-F in polyacrylamide gel (note log scales).
I09
Curve 5.2 indicates a linear relationship be tween ^protein
migration velocities and log voltage applied between 10 and 250
volts. A linear plot was also obtained between log current per gel 
log
tube and ^migration velocities of BSA-F and insulin—F in the range 0.1 
to 1.6 mA (figure 5.3).
The steeper and non-linear portions of the curves in figures 
5.2 and 5.3 are believed to be due to the effect of protein 
diffusion in poly aery lamide gels. Band broadening was observed after 
the longer run times required during lower electric field strength 
migration experiments. Thus it is considered that 
migration velocities ; recorded at lower field strengths v>ere» a 
result of protein movement due to both diffusion and electrophoresis; 
at 10 volts and above, the contribution of diffusion becomes minimal 
in comparison with electrophoretic migration. The linear plot of 
current (0.03 to 0.4 mA per gel rod) versus voltage in the range 3 to 
15 volts shown in figure 5.4 suggests that no changes in system 
resistance occur around 10 volts (i.e. the voltage below which 
linearity was lost).








































FIGURE 5.2 EFFECT OF APPLIED VOLTAGE ON 
MIGRATION VELOCITIES OF BSA-F 
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FIGURE 5.3 EFFECT OF CURRENT ON MIGRATION VELOCITIES OF 
























FIGURE 5.4 EFFECT OF APPLIED VOLTAGE ON CURRENT PER 
GEL TUBE IN POLYACRYLAMIDE ROD GEL ELEC­
TROPHORESIS
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through polyacrylamide gels under similar conditions. This is not 
surprising since BSA has molecular weight an order o£ magnitude 
higher than insulin ( i.e. 5 .7 x 10* compared w ith 5.777 x 10^). 
However the progress of molecules of less than 2 x 104 molecular 
weight such as insulin, has been found to be slower than expected on 
the basis of molecular weight considerations alone [2 09]. Although 
BSA is a much larger molecule than insulin, the rod-like shape of the 
former (15 x 3 nm) may enable it to migrate in a serpentine fashion 
(section 1.5.4.1.3.) thus giving migration velocities comparable with 
the insulin dimer ( 2 x 4  nm), the form predominating in solution 
[192].
In the absence of data relating to surface charge of BSA-F and 
insulin-F molecules, it is difficult to speculate about the influence 
of this factor on the migration velocities obtained.
For electrophoretic separations, it is normally advised that rod 
gel electrophoresis be performed using a minimum of approximately 
100 volts or 1 mA per gel (section 1.5.4.4.iv.). Electrophoretic 
migration of BSA-F and insulin-F in 5T 5C polyacrylamide gel could 
not be detected below approximately 3 volts in the present study, 
although results indicate that low voltage (compared with 
conventional techniques) gel electrophoresis i.e. in the range 3.5 to 
15 volts (0.03 to 0.4 mA per rod) is possible.
(c) Temperature
Figure 5.5 shows that the electrophoretic migration velocity of 
insulin-F (at a constant 3 0 volts) increased as temperature increased 






























FIGURE 5.5 EFFECT OF TEMPERATURE ON INSULIN-F
MIGRATION VELOCITY IN POLYACRYLAMIDE 
ROD GEL ELECTROPHORESIS
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Ionic mobility and free diffusion Increase (the latter was 
observed as protein sample band broadening) with the raising of 
temperature because gel viscosity Is reduced [135]. In addition, due 
to a decrease in gel and buffer electrical resistance, current was 
found to rise with increasing temperature (as shown in figure 5.6) 
which in turn may lower resistance. The above factors caused an 
overall increase in the insulin-F migration velocity of approximately 
2% per degree rise of temperature? Morris and Morris [210] found that 
protein mobility increased by about 2.4% for the same temperature 
increase.
The effect of temperature on protein stability was not 
determined but due to the possibility of temperature related protein 
conformation changes as well as the points discussed above, it is 
clear that electrophoresis experiments should be carried out at 
constant temperature using a constant voltage or constant current 
power supply (see section 1.5.4.4.iv.).
(d) Buffer electrolyte Ionic strength
The influence of buffer ionic strength on the migration 
velocities of BSA-F and insulin-F after electrophoresis at a constant 
3 0 volts is shown in figure 5.7. It can be seen that as ionic 
strength was decreased from 0.5M to 0.05M, an increase in protein 
migration velocity was observed. However a further reduction in 
ionic strength from 0.05M to 0.001M resulted in decreased protein 
migration velocities. This is in contrast to the results of Gross 
[211] who found that mobility was approximately inversely 
proportional to the square root of the ionic strength. Absolom et 


















FIGURE 5.6 RELATIONSHIP BETWEEN ROD GEL ELECTRO­
PHORESIS TEMPERATURE AND MEAN CURRENT 
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with a reduction in ionic strength but only ionic strengths in the 
range 0.01 to 0.05 M were investigated.
Insulin-F was found to migrate faster than BSA-F in all 
conditions. Sample bands became broader as buffer ionic strength was 
reduced; this has also been noted by Maurer [13 5] but not explained.
The above results are inconsistent with electrophoretic theory 
which states that electrophoretic mobility decreases with increasing 
ionic strength (1.5.4.4.iii.). However, the findings of this study 
may be explained by consideration of the effect of ionic strength 
upon another parameter in electrophoresis, the electric current.
Figure 5.8 shows that current decreased as buffer ionic strength was 
lowered due to an increase in electrical resistance. The effect of 
current on protein migration is shown in figure 53. It is 
considered that the reduction in migration velocities caused by the 
decreasing current outweighs the expected increase in protein 
migration velocity with reduced ionic strength.
It was felt that the slight alteration of buffer ionic strengths 
caused by adjusting to pH 7.4 before use was justified in light of the 
influence of pH on protein migration velocities which is discussed 
below.
On the basis of the above results it was was decided that 0.025M 
phosphate buffer would be most suitable for use as an electrolyte in 
2-compartmental insulin electrophoretic release studies (section 
6 3.) since high rates of migration using low voltages and/or 
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( e) Electrolyte pH
The Coomasie Blue staining procedure described In section
5.2.I.e. produced distinctive dark bands (representing BSA and 
Insulin) In polyacrylamide gels.
Figure 5.9 indicates that the direction of protein migration 
was altered with changing pH. BSA appeared to show no net migration 
at pH 5.0 and by interpolation, insulin would be expected to remain 
stationary at about pH 5.5. These values represent the isoelectric 
points (pi) of the above proteins and show reasonable agreement with 
literature values (BSA = 5.1 and insulin = 5.7 j section 2.1.1.). At 
the isoelectric point, the number of positively and negatively 
charged groups on a protein are balanced. As pH is increased, 
ionization of carboxyl groups predominates giving the molecules an 
increasing negative charge. Reduction of pH results in the increased 
ionization of amino groups resulting in a positively charged protein. 
The different isoelectric points and curve shapes (figure 5.9) 
obtained for BSA and insulin reflect the diversity in molecular 
structure of the 2 proteins. By convention, the sign of 
electrophoretic mobility is the same as that of the net charge of the 
protein [ 13 6].
Although PAGE is usually limited to the range pH 3 to 11 [154], 
it is considered that pH related effects in addition to ionization 
can affect electrophoretic mobility of proteins, by for example, 
producing degradation and conformational changes which may result in 
burying or exposure of ionizable groups.
The migration velocities of unlabelled BSA and insulin were 
comparable with those obtained using BSA-F and insulin-F during this 























FIGURE 5.9 EFFECT OF BUFFER ELECTROLYTE pH 
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protein does not induce major change in the structures of BSA or 
insulin.
This investigation illustrates the importance of adequate 
buffering during polyacrylamide gel electrophoresis of proteins.
(f) Percentage total monomer In gel
Figure 5.10 shows the electrophoretic migration velocities of 
insulin-F and BSA-F in polyacrylamide gels of various total monomer 
concentrations (T); the migration velocities of both proteins 
decreased with increasing T. This is probably due to decreasing 
polyacrylamide gel porosity as monomer concentration is increased 
(section 1.5.4.1.1.). Insulin exhibits a linear relationship between 
migration velocity and T in the range 10 to 2 5T; the deviation from 
linearity below 10T is considered to be due to protein diffusion 
combining with electrophoresis to produce higher migration velocities 
than expected. Protein diffusion (insulin-F and BSA-F) was found to 
increase with decreasing T in polyacrylamide gels as evidenced by 
band broadening as monomer concentration was reduced.
BSA-F shows a different curve to that obtained for insulin, a 
marked reduction in migration velocity was observed as T increased 
from 5 to 15T with a smellier decrease noted between 15 and 25T. It 
is considered that the larger BSA molecule (m.w. 5.7 x 10^) becomes 
increasingly sterically hindered compared with insulin (m.w. 5.777 x 
103) as polyacrylamide gel porosity decreases (with increasing T).
At 20-25T, a limiting pore size is approached (section I.5.4.I.2.) and 
passage of the BSA-F molecule becomes increasingly difficult.
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relative mobility) and T is generally accepted and was first 
demonstrated in polyacrylamide gels by Hedrick and Smith [156]; this 
type of curve is used in the estimation of protein molecular weights 
(see section 1.5.4.3.a). Figure 5.11 shows the relationship between 
log migration velocities of BSA-F and insulin-F and T in 
polyacrylamide gels; both proteins show linear relationships which is 
in agreement with the general findings of Hedrick and Smith [156].
(g) Crosslinking
The influence of crosslinking (C) with Bis on the 
electrophoretic migration velocities of BSA-F and insulin-F through 
polyacrylamide gels is shown in figure 5.12. With both proteins, 
increased crosslinking caused an initial reduction in migration 
velocities which reached minimum values at 6-8C; then as Bis was 
increased from 8 to 30C, migration velocity increased. This is in 
agreement with the results of Rodbard et al. who investigated the 
effect of Bis using 7 J5T polyacrylamide gels containing differing 
amounts of crosslinker and found that the mobilities of a number of 
proteins (including BSA) exhibited a minimum at 5-8C [167]. Thorun 
[213] demonstrated a linear relationship between log mobility and the 
square root of crosslinking in polyacrylamide gels but only made 
determinations in the range 0.1 to 5C.
On the basis of the above results and those found from insulin 
permeation experiments (section 4.6.), it is considered that changes 
in polyacrylamide gel pore size with increasing Bis concentration are 
reponsible for the observed effects on protein migration velocities; 
it is believed that after initially decreasing in size as 
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FIGURE 5.12 EFFECT OF CROSSLINKING(AT 5T) ON MIGRATION VELOCITIES 
OF BSA-F AND INSULIN-F IN ROD POLYACRYLAMIDE GEL 
ELECTROPHORESIS
bound together by the numerous crosslinkages results in larger pores 
as crosslinking increases above 8C. This "bundling" or "clustering" 
of polymer chains may account for the physical and optical properties 
of gels observed during the present study, i.e. polyacrylamide gels 
of 8C and above became increasingly opaque and mechanically weak. 
Fawcett and Morris [205] made similar observations about gel 
appearance and found that polyacrylamide gel pore size showed a 
minimum when C was about 5 per cent.
The migration velocity of BSA-F was reduced to a greater extent 
than that of insulin by increased gel crosslinkingr probably because 
greater obstruction was experienced by the larger BSA-F molecules as 
pore size became reduced.
For the purposes of proposed 2-compartmental delivery studies 
(section 6), crosslinking in polyacrylamide gel should provide a 
minimal pore size to limit diffusion; on the basis of the above 
discussion, a value of 7C was selected.
(ii) PolyHEMA rod gel electrophoresis
It was found that neither BSA-F nor insulin-F migrated 
electrophoretically in polyHEMA gels of 6 0, 7 0 and 80 T 
(uncrosslinked and crosslinked with 0.5% EGDMA) to a detectable 
extent, even when a potential difference of up to 27 5 volts was 
applied. This was believed to be due to the smaller mean pore radius 
of polyHEMA gels, typically reported as 0.4 to 0.5 nm [85,214] for 
60T gels compared with about 2-3 nm for 5T polyacrylamide gels 
(section 1.5.4.1.2.).
Although insulin permeability through polyHEMA (60T) membrane
147
has been demonstrated [200], it is considered that protein migration 
is prevented by uni-directional electrophoresis where molecules 
cannot escape from size limiting pores. In the permeation process 
however, insulin molecules are able to move in all directions and 
find an alternative route through the polymer network; a method for 
investigating the possible occurrence of this phenomenon might 
involve repeated electric field reversal during electrophoresis to 
help free protein molecules "trapped" within the gel pores.
Polyacrylamide gel was therefore utilised as the supporting 
medium for electrophoresis (in preference to polyHEMA) during the 
remainder of this study.
148
IN VITRO ELECTROPHORETIC DRUG RELEASE USING A 2-COMPARTMENT MODEL
6 . In vitro electrophoretic drug release using a 2-compartment model
It was established in section 5 that a low voltage (5 to 3 0V) 
electrophoresis technique could be utilised In a reproducible manner 
to produce migration of BSA (F) and insulin (F) in polyacrylamide gel 
rods of various formulations. To assess the possibility of using 
physiologically acceptable, low voltage electrophoresis to produce 
controlled drug delivery, a 2-compartment apparatus (figure 6.1) was 
proposed.
It was intended that polyacrylamide gel should be used to form a 
virtual barrier to the permeation of drug from a reservoir. From 
permeation data described in section 4.6., it was calculated that 
polyacrylamide gel discs of 10 mm thickness and 19 mm diameter could 
be used to limit the permeation of insulin through 3 0T 7C gels, as 
well as hyoscine hydrobromide, hyoscine methyl chloride and 
propranolol hydrochloride through 40T 7C gels. An electric field 
generated by the use of low (5 to 20 V) voltages was then studied as 
as method for electrophoretically eluting drug from a reservoir 
through the polyacrylamide gel disc.
6.1. 2-compartment apparatus for electrophoretic drug release
Perspex of 0.6 cm thickness was employed in a specially 
constructed apparatus (figure 6.1).
Loss of insulin by adsorption onto glass and plastics is well 
known [193]. In this study, 95.2% and 94.7% of ini tied insulin 
concentration remained after 2 weeks storage at 3 0°C, away from 
light, of donor solutions (section 6.3.) stored in perspex and glass 
respectively. Donor solutions (section 6*4) of hyoscine 
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FIGURE 6.1 2-COMPARTMENT APPARATUS FOR
ELECTROPHORETIC DRUG RELEASE
(at pH 3.0) showed no significant loss after similar treatment. The 
level of insulin loss in the perspex apparatus for electrophoretic 
drug release over a period of 3 days (normal experimental time) was 
expected to be approximately 1% and considered acceptable.
2 cube-shaped vessels measuring 6 cm x 6 cm x 6 cm formed the 
donor and receptor compartments. A polyacrylamide gel disc was 
placed between and connected the 2 compartments through an orifice of 
2.25 cm diameter in the centre of one wall of each chamber. An "O" 
ring gasket was placed around the glass mould which enclosed the gel 
disc and ensured effective sealing of each compartment. When 
polyacrylamide gel membranes were used (sections 4.4.2. and
6.4.2.2.e.), they were simply clamped between the receptor and donor 
compartments.
A lid sealed each chamber and was screwed down securely. Small 
d.c. motors (Radio-Spares 336-321, RS Components Ltd., Corby, 
Northants, U.K.) were used to drive PTFE stirring paddles which 
revolved at 240 r.p.m. to ensure thorough mixing of donor and receptor 
solutions; to avoid solution frothing, a slower speed of 12 0 r.p.m. 
was used in studies involving insulin release.
An electric field, running perpendicular to the faces of the gel 
disc, was created by passing a current through the system by means of 
circular platinum electrodes embedded in the chamber walls. To 
minimise gas evolution at these electrodes, platinum wire used in 
their construction.was treated in the following manner [186].
Electrodes were immersed in 50 cm^ of chloroplatinic acid (BDH 
Chemicals) and platinum was electrodeposited on each electrode by 
passing a current of 10 mA through it for about 3 minutes after which
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time the electrode surface became black.
Electrophoresis was performed at constant voltage using a 
stabilised power supply (WEIR 4000, Electroplan, Royston, 
HeAordshire, U.K).
6.2 General method used in 2-compartment release studies
Polyacrylamide gel discs (of 19 mm diameter and 10 mm thickness) 
were removed from buffer solution used for storage and inspected to 
ensure flat surfaces and uniform composition. A gel disc (plus 
mould) was placed into the 2-compartment apparatus as described in 
section 6.1. and the effectiveness of the rubber gasket seal tested 
by filling one compartment with buffer solution; liquid seepage into 
the second compartment being indicative of ineffective sealing.
After filling both chambers with buffer solution, pre­
electrophoresis was performed for 1 hour at the proposed running 
voltage.
The apparatus was emptied and dried before being placed into a 
water bath maintained at 3 0+0.1°C. 17 5 cm3 of donor (buffer 
containing drug) and receptor (drug-free buffer) solutions, 
equilibrated at 30°C in the waterbath, were introduced into the 
appropriate compartments and the lids secured.
After stirring of solutions for approximately 1 minute, samples 
were removed from both compartments and electrophoresis commenced 
immediately afterwards. Subsequently, sampling was at timed 
intervals from the receptor solution to monitor the increase in drug 
concentration in that compartment. However, a sample was withdrawn 
from the donor solution at the end of each experiment to determine 
the extent of drug depletion in the donor compartment. When
necessary, donor and receptor volumes were replenished with the 
appropriate solution after sampling and the resulting dilution taken 
Into account when analysing the release data. The voltage and 
current were measured regularly (using a multimeter) during the 
course of electrophoretic release studies, which were generally 
conducted for a period of 3 to 4 days.
Donor and receptor pH was measured at the start and end of most 
experiments.
Data is presented (figures 6.2 to 6.18) as receptor drug 
concentration (as a percentage fraction of the initial donor 
concentration) versus time. Each data point represents the mean of 2 
determinations with vertical bars indicating experimental limits.
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63. Electrophoretic release of Insulin through polyacrylamide gel 
discs
Porcine insulin and radlolabelled drug was dissolved In 0.025M 
phosphate buffer, at pH 7.4, to produce a concentration of 2.85 I.U. 
cm J (donor). Gentle stirring (by means of a P.T.F.E. coated 
magnetic bar) for several hours at room temperature was necessary to 
completely dissolve the protein and produce a clear solution; excessive 
agitation caused foaming of the solution and was avoided both during 
donor solution preparation and electrophoretic delivery experiments. 
Release of insulin by electrophoresis was assessed by monitoring 
increase in drug concentration in the receptor compartment.
6.3.1. Verification of electrophoretic insulin release by U.V.
spectrophotometric assay
To ensure that insulin assay by gamma counting was not 
detecting a radiolabelled degradant of the hormone, insulin release 
due to electrophoresis using a voltage of 15 V and a current of 3+0.4 
mA through a 3 0T 7C polyacrylamide gel disc was determined by 
assaying receptor drug concentration by both U.V. spectrophotometry 
and gamma counting.
6.3.2. Factors affecting the electrophoretic release of Insulin
a) Applied potential difference
Polyacrylamide gel discs of 3 0T 7C composition were employed to 
investigate electrophoretic insulin release at 0, 2.5 (0.3), 5 (0.7),
10 (2.0) and 15 (3.1) volts (mean current is shown in parentheses).
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b) Polyacrylamide gel concentration
The release of Insulin through 20, 25 and 30T polyacrylamide 
gels (all 7% crosslinked) at an applied potential gradient of 5 volts 
was determined.
c) Alteration of electric field conditions during release
To evaluate the feasibility of using electrophoresis to produce 
variable drug release rates, the release of insulin through 3 0T 7C 
polyacrylamide gel discs was monitored using cycling voltage levels. 
5V and 10V potential differences were applied sequentially; in both 
cases the voltages were applied for approximately 24 hours each.
The insulin release profile obtained when a 5 volt potential 
difference was repeatedly switched on and off (at 24 hour intervals) 
during release was also determined.
156
6.4. Electrophoretic release of hyoscine methyl chloride,
propranolol hydrochloride and hyoscine hydrobromide through 
polyacrylamide gel discs
Factors affecting the electrophoretic release of insulin through 
polyacrylamide gel discs were studied in section 6 3.2. The 
possibility of using low voltage polyacrylamide gel electrophoresis 
(PAGE) to provide the controlled release of drugs of lower molecular 
weight was also assessed. Three drugs were selected for this 
purpose: hyoscine methyl chloride, propranolol hydrochloride and 
hyoscine hydrobromide (section 2.1.1.). Although gel electrophoresis 
of low molecular weight drug molecules e.g. antibiotics has been 
described [56,166], low voltage polyacrylamide gel electrophoresis of 
the drugs used in the present study has not been reported previously.
To ensure complete ionization of drugs, i.e., the form most 
appropriate for electrophoresis, the use of a buffer (Mcllvane's 
citrate-phosphate) at pH 3.0 was proposed.
6.4.1. Buffering capability of citrate-phosphate buffer during 
electrophoresis
Changes in donor and receptor electrolyte pH were observed 
during electrophoretic insulin delivery (see section 6.5. below) and 
it was therefore decided that the buffering capability of Mcllvane's 
citrate-phosphate buffers of various ionic strengths (intended for 
use in delivery experiments involving hyoscine hydrobromide, 
propranolol hydrochloride and hyoscine methyl chloride) should be 
determined. A 2-compartmental electrophoretic delivery apparatus 
previously described (section 6.1. and figure 6.1) with 40T 7C 
polyacrylamide gel discs of 10 mm thickness was used. Mcllvane's
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citrate-phosphate buffer, pH 2.85, was prepared and diluted to give 
solutions of ionic strengths ranging from 1.6 x 10”3M to 1.6 x 10”1M. 
Dilution caused buffer pH to increase up to a maximum value of pH 3 3 
for the 1.6 x 10"3 M solution. Drug-free buffer solutions were placed 
into the donor (anolytic) and receptor (catholytic) compartments of 
the apparatus and a mean current in the range 03 to 3 3 mA passed 
through the system at a constant 10 volts. After approximately 100 
hours of pre-electrophoresis at 3 0+0.1°C, donor and receptor 
electrolyte pH's were determined. The changes in pH of buffer 




Change in pH after 
pr e-electrophor esi s
Donor Receptor
Mean current during 
pre-electrophoresis
16 -0.6 +0.5 3 .3 mA
8 -0.7 +0.8 2 .6 mA
4 -0.7 +0.8 2.2 mA
1.6 -0.7 +0.8 2 .2 mA
0.16 -0.6 +1.7 0.5 mA
Table 6.1 The Influence of ionic strength on the effectiveness 
of Mcllvane's citrate-phosphate buffer during pre­
electrophoresis
The change in donor solution pH during electrophoresis appears to be 
little affected by buffer ionic strength, and as expected (see 
section 1.5.4.4.V) decreased (by 0.6 to 0.7 pH units). However,
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increasing the ionic strength of the receptor buffer resulted in a 
smaller pH change in that compartment. Although 0.04M (initially at 
pH 3.0) buffer allowed pH fluctuations that might be considered 
unacceptable, it was decided that it should be used in subsequent 
electrophoretic release studies involving hyoscine methyl chloride, 
propranolol hydrochloride and hyoscine hydrobromide, for the 
following reasons.
The above 3 drugs have pKa's in aqueous solution of at least 
7 35 (at 30°C) and will therefore be completely ionized over the 
pH range 23 to 3.8; secondly, high ionic strength buffers should be 
avoided as they can give rise to excessive heat generation during 
electrophoresis (section 1.5.4.4.iv). Finally, a 0.04M citrate- 
phosphate buffer is comparable with the 0.025 M ionic strength 
phosphate buffer employed during studies of electrophoretic release 
of insulin (section 6.3).
6.4.2. Electrophoretic release of hyoscine methyl chloride 
6.43JL. Verification of electrophoretic release of hyoscine methyl 
chloride by HELC
Liquid scintillation counting was employed to monitor drug 
concentration in the receptor. The following procedure was performed 
to ensure that this assay was detecting hyoscine methyl chloride and 
not a radiolabelled degradant.
During the course of electrophoretic drug release at a constant 
10 volts, receptor solution which, on the basis of scintillation 
counting, had a concentration of 1.4 x 10“5 mol dm-3 was assayed by 
HELC (section 2 3.6.) along with a hyoscine methyl chloride standard 
solution of 1.4 x 10“3 mol dm"3.
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6 .4.2.2. Some factors affecting electrophoretic release of hyoscine 
methyl chloride
Radiolabelled donor solution was prepared by dissolving 
the drug and tritiated hyoscine methyl chloride in 0.04M citrate- 
phosphate buffer, pH 3.0, to produce a 2.82 X 10-4 mol dm“3 
solution.- Unless stated otherwise, 40T 7C polyacrylamide gel discs of 
10 mm thickness and 19 mm diameter were employed.
a) Applied voltage
Hyoscine methyl chloride concentration in the receptor 
compartment was monitored at timed intervals whilst 0, 5 (1.5 mA), 10 
(3 mA), 15 (5 mA) or 20 (8 mA) volts were applied to the 2- 
compartment delivery apparatus (mean current is shown in 
parentheses).
b) Polyacrylamide gel concentration
The electrophoretic release of hyoscine methyl chloride through 
polyacrylamide gels of 3 0, 35 and 40T (7C) composition was 
investigated at an applied potential difference of 10 volts.
c) Alteration of electric field conditions during delivery
The electrophoretic release of hyoscine methyl chloride through 
polyacrylamide gel discs was monitored whilst a potential difference 
of 10 volts applied across the delivery apparatus was either 
( i) repeatedly switched on and off at approximately 24 hour intervals, 
or ( ii) maintained at a constant 10 volts.
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d) Temperature
The effect of temperature on the electrophoretic release (at a 
potential difference of 10 volts) of hyoscine methyl chloride was 
assessed by performing delivery experiments in constant temperature 
water baths at: 25,3 0,35,40 and 45°C.
e) Polyacrylamide gel thickness
40T 7C polyacrylamide gel sheets of 1.5, 5.5 and 10 mm 
thicknesses were prepared by a method previously described (section 
3.I.4.C.). Discs of 35 mm diameter were stamped out from gel sheets 
using specially constructed cutting rings and clamped between donor 
and receptor compartments of the electrophoretic release apparatus.
In the absence of glass moulds around gel discs the exposed 
polyacrylamide gel surface area in each compartment was increased 
from 2.8 to 4.0 cm2, and this was taken into account during analysis 
of electrophoretic release data. After the initiation of 
electrophoretic drug release, sampling from the receptor solution was 
carried out at 60 minute intervals for the first 7 hours, with a 
final sample after 24 hours of delivery.
f) Donor drug concentration
Hyoscine methyl chloride was dissolved in 0.04M citrate- 
phosphate buffer to produce donor solutions of the following 
concentrations: 2.82 x 10”2, 2.82 x 10“3 , 2.82 x 10”4 and
2.82 x 10”5 mol dm”3. A potential difference of 10 volts was applied 
across the delivery apparatus.
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g) Duration of electrophoretic release
To determine the limit of zero-order release .kinetics with 
respect to time, electrophoretic delivery of hyoscine methyl chloride 
at a constant potential difference of 10 volts was continued for 10 
days.
6.4.3 • Electrophoretic release of propranolol hydrochloride and 
hyoscine hydrobrcmide through polyacrylamide gel discs
Drug donor solutions were prepared by dissolving hyoscine 
hydrobromide and propranolol hydrochloride in 0.04M citrate- 
phosphate buffer to produce 2.60 x 10”  ^ and 3.3 8 x 10“  ^ mol dm”  ^
solutions respectively. 40T 7C polyacrylamide gel discs of 10 mm 
thickness and 19 mm diameter were used for release experiments.
6 *4.3.1. Effect of applied voltage on the electrophoretic release of 
hyoscine hydrobrcmide and propranolol hydrochloride
Potential differences of 5 and 10 volts were applied to the 
delivery apparatus and the concentration of propranolol hydrochloride 
and hyoscine hydrobromide in the receptor compartment monitored by 
HPLC assay (sections 2.2.4 and 2.2.5).
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6.5• Results and discussion
6.5.1. Electrophoretic Insulin Release
(1) Donor drug loss during 2-compartment Insulin release studies 
Donor insulin concentrations decreased as receptor drug 
concentration increased during the course of electrophoretic release 
studies; approximately 2% (of the original donor concentration) of 
insulin usually remained unaccounted for at the end of experiments of 
3 to 4 days duration. Drug loss was believed to be due to insulin 
retention within the polyacrylamide gel disc and by adsorption onto 
the walls of the electrophoresis apparatus (section 6.1).
( ii) Verification of electrophoretic insulin release by U.V. 
spectrophotometry 
Figure 6.2 shows the receptor concentration of insulin 
determined by U.V. spectrophotometric and gamma counting assays. 
Although only 3 data points were used, data from the 2 assay
procedures was comparable suggesting that the gamma counting assay
method was probably detecting insulin and not a radiolabelled 
degradant. Techniques such as HPLC and radiommunoassay may yield 
more information regarding insulin stability but were not used in the 
present study.
The slope of the curve in figure 6.2 indicates an insulin release
rate of 15.4 I.U. per day.
( iii) Factors affecting electrophoretic release of insulin 
(a) Applied potential gradient (electric field strength)
In figure 6 3 the effect of applied voltage on the 
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FIGURE 6.3 ELECTROPHORETIC RELEASE OF INSULIN 
THROUGH 30T 7C POLYACRYLAMIDE GEL 
VERSUS APPLIED VOLTAGE
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remained undetected in the receptor compartment after more than 100 
hours of electrophoresis indicating that 30T 7C polyacrylamide gel 
discs provided an adequate barrier (over a period of 4 days) to the 
permeation of insulin from the donor solution (as postulated in 
section 4.6).
Application of a constant 2.5 volts to the electrophoresis 
apparatus was found inadequate to produce a detectable insulin 
release rate; however zero-order electrophoretic drug release was 
obtained by application of constant voltage at 5,10 and 15 volts; 
linear correlation coefficients for the release profiles were 0.9 98 
(5 V), 0.992 (10V) and 0.99 8 ( 15 V).
Insulin release rateswere calculated from the slopes of the 
release profiles in figure 6.3 and were found to increase with 
applied voltage. Insulin release rates (I.U. per day) were 8.1 (5V),
12.8 (10V) and 16.5 (15V) and a plot of insulin release rate versus 
applied voltage (figure 6.4) indicates an approximately linear 
relationship in the range 5 to 15V. The daily insulin requirement of 
diabetics is found to vary widely e.g. between 10 and 100 I.U. [193].
The linear relationship between applied voltage (5 to 15 volts) 
and insulin release rate is analogous to that found between applied 
voltage (10 to 275 volts) and insulin-F migration velocity in rod gel 
electrophoresis (section 5.2.1.). Thus the electric field generated 
within the rod gel and 2-compartment electrophoretic release 
apparatus is believed to be directly proportional to applied voltage. 
Loss of linearity below 10 volts in the relationship between applied 
voltage and insulin-F migration velocity in rod gel electrophoresis 
























FIGURE 6.4 INSULIN RELEASE RATE VERSUS
APPLIED VOLTAGE IN 2-COMPART- 
MENTAL ELECTROPHORETIC RELEASE 
THROUGH 30T 7C POLYACRYLAMIDE 
GEL DISCS
167
10V in 2-compartmental release studies because use of 30T 7C 
polyacrylamide gels reduced the effect of insulin diffusion 
previously observed in 5T 5C rod gels.
Figure 6.5 shows that current increased from 0.6 mA to 0.8 roA in 
the first 24 hours of electrophoretic release of insulin (at a 
constant 5V) and then decreased gradually to a value of 0.7 mA after 
approximately 72 hours. The initial increase in current is considered 
to be due to decreased electrical resistance of the polyacrylamide 
disc as the charge-carrying insulin molecules pass into the gel. The 
subsequent decrease in current is believed to result from a number of 
factors including buffer—ion migration and electrolytic effects 
(section 1.5.4.4.V). Similar profiles i.e. an initial increase 
followed by a decreasing and then more stable current were found at 
10 and 15 volts.
(b) Polyacrylamide gel concentration
Increasing the total monomer concentration (T) of polyacrylamide 
gel discs in the range 20 to 30T was found to result in a decreased 
rate of electrophoretic insulin release (at zero-order) at a constant 
5V (figure 6.6). This is considered to be due to the decrease in 
polyacrylamide gel porosity with increasing T which causes greater 
retardation of the insulin molecule.
Insulin release rates were determined from the slopes of drug 
release profiles and found to be 7.5 (30T gel), 9.0 (25T gel) and
10.9 (20T gel) I.U. per day. A plot of insulin release rate versus T 
indicates a linear relationship (figure 6.6) analogous to that 
previously found between insulin-F migration velocity and T (in the 












FIGURE 6.5 ELECTRIC CURRENT PROFILE DURING 
ELECTROPHORETIC INSULIN RELEASE 
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FIGURE 6.6 EFFECT OF PERCENTAGE TOTAL 
MONOMER (T) ON INSULIN 
RELEASE RATE THROUGH POLY­
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The above results Indicate that desired electrophoretic Insulin 
release rates may be obtained by simple manipulation of applied 
voltage (field strength) and polyacrylamide gel formulation.
(c) Alteration of electric field conditions
(I) Repeated switching on and off of electric field
Figure 6.7 shows receptor insulin concentration during 
electrophoretic release employing the intermittent application of 5 
volts; the release profile has 4 regions:
(1) After a lag time of approximately 4 hours, insulin is released 
at 8.3 I.U. day”1 (i.e. at 5 volts).
(2) Drug release rate falls to zero at 2 4 hours (corresponding to 
the removal of the electric field at that point).
(3) Re-application of an electric field (5 volts) effects an insulin- 
release rate of 8.4 I.U. day”1.
(4) When the voltage is switched off, insulin release stops.
Interestingly (excepting the initial lag period), insulin 
release commences and ceases immediately on application and removal 
of the electric field - a highly desirable feature in terms of 
obtaining true controlled drug release.
(II) Application of 5 and 10V alternately
Figure 6.8 shows receptor insulin concentration during 
electrophoretic release using 5 and 10 volts, applied alternately; 






















FIGURE 6.7 ELECTROPHORETIC RELEASE OF INSULIN 
THROUGH 30T 7C POLYACRYLAMIDE GEL 
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FIGURE 6.8 ELECTROPHORETIC RELEASE OF INSULIN 
THROUGH 30T 7C POLYACRYLAMIDE GEL 
AT AN ALTERNATING 5 AND 10 VOLTS
(1) An initial release rate of 8.0 I.U. day"'*" corresponding to an 
applied potential difference of 5 volts.
(2) Between 24 and 48 hours a constant 10 volts was applied and 
insulin release rate was found to rise to 23 .4 I.U. day”1.
(3) A release rate of 8.4 I.U. day”1 was observed when 5 volts was
applied once again between 48 and 72 hours.
(4) Re-application of 10 volts produced a release rate of 13.9 I.U. 
day”1 (72 to 96 hours).
(5) Insulin was released at 5.5 I.U. day”1 between 96 and 120 hours 
at a constant 5 volts.
Although based on only 3 data points, each phase indicates zero- 
order release. Insulin release rate during phase (2) was higher than 
expected on the basis of a 12.8 I.U. day”1 rate previously obtained 
(figures 6.3 and 6.4) when a potential difference of 10 volts was 
also employed. A reduction in applied voltage from 10V to 5V at 4 8 
hours caused a fall in insulin release rate to 8.4 I.U. day”1. 10 
volts (phase 4) and 5 volts (phase 5) produced release rates of 13.9 
and 5.5 I.U. day”1 respectively. These values were lower than 
obtained during earlier phases utilising the same voltage conditions;
it is believed that donor drug depletion accounts for the apparent
decrease in release rate. However, the marked increase in insulin 
release rate on going from phase 1 to phase 2 is difficult to 
explain. It is possible that insulin concentration changes within 
the gel, caused by the voltage changes described, are responsible. In 
addition, physical changes in polyacrylamide gel caused by the 
electric field changes or swelling cannot be ruled out. The 
effects of electrode polarization may have resulted in field strength
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changes not detected by voltage and current measurements.
Since intermittent application of an electric field resulted 
in more reproducible release rates, it is considered that this type 
of electric field change would be most useful for obtaining 
controlled drug release. It is envisaged that release rate could be 
modulated by alteration of (D.C.) frequency of electric field 
application.
(iv) Buffer electrolyte pH changes during electrophoretic Insulin 
3 release
Buffer pH's of donor and receptor compartments were found to 
change during the course of electrophoretic release experiments.
Donor pH increased by between 0.5 and 1.0 pH unit while that of the 
receptor decreased by the same amount. The above pH changes can be 
explained on the basis of electrolysis effects (section 1.5.4.4.v) 
and no attempts were made to improve buffering capacities. However, 
the effect of ionic strength of Mcllvane's citrate-phosphate buffer 
(for electrophoretic release studies) on buffering capability was 
studied (section 6.4.1.).
6 .5.2• Electrophoretic release of hyoscine methyl chloride
(i) Verification of electrophoretic hyoscine methyl chloride release
The radiolabelled receptor solution sample produced an identical 
peak to that obtained after HELC of a 1.4 x 10”  ^mol dm”  ^ standard 
solution of hyoscine methyl chloride (figure 2.9). This suggested 
that degradation of hyoscine methyl chloride probably did not occur 
during release experiments and that the liquid scintillation assay of
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this drug was satisfactory.
(11) Factors affecting electrophoretic release of hyoscine methyl
chloride
(a) Applied potential difference
Figure 6.9 shows hyoscine methyl chloride electrophoretic 
release rates using various applied voltages (field strengths).
Drug remained undetected in the receptor after 72 hours at zero 
volts. This confirms the postulation made in section 4.6. that 
40T 7C polyacrylamide gel discs of 10 mm thickness would limit the 
permeation of hyoscine methyl chloride to less than 0.7% in 4 days.
Application of between 5 and 20 volts produced zero-order drug 
release; linear correlation coefficients of hyoscine methyl chloride 
release profiles were 0.993 (5 volts), 0.999 (10 volts), 0.998 (15 
volts) and 0.999 (20 volts). Hyoscine methyl chloride release rate 
increased with applied voltage; shortest lag times for release 
(ranging from approximately 0.5 to 4 hours) were associated with 
the highest release rates. A hyoscine methyl chloride release rate 
equivalent to 3.0 x 10"6 mol day"1 was found using 40T 7C gels at a 
constant 10 volts.
Under similar electrophoresis conditions, a greater fraction of 
hyoscine methyl chloride was released compared with percentage 
fraction insulin released (section 6.5.1.). This was probably due 
to the smaller molecular size of hyoscine methyl chloride (section
2.1.1.), resulting in faster electrophoretic migration. In the 
absence of information concerning porcine insulin surface charge 
under the conditions used in the present study, it is difficult to 



































FIGURE 6.9 EFFECT OF APPLIED VOLTAGE ON 
ELECTROPHORETIC RELEASE OF 
HYOSCINE METHYL CHLORIDE THROUGH 
40T 7C POLYACRYLAMIDE GEL
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electrophoretic release rates of hyoscine methyl chloride and 
insulin.
A plot (figure 6.9) of applied voltage versus hyoscine methyl 
chloride release rate (mol day"^) indicates a linear relationship 
between 5 and 20 volts; the curve loses linearity below 5 volts. 
Extrapolation of the straight line portion to the voltage axis 
suggests that approximately 4 volts must be applied to the 
electrophoretic release apparatus before drug release is effected. 
This may indicate a degree of drug ■immobilization* by the 
polyacrylamide network which is overcome by application of an 
appropriate electric field produced by approximately 4 volts 
potential difference.
(b) Polyacrylamide gel concentration
Figure 6.10 shows the effect of increasing T on hyoscine methyl 
chloride release rate (mol day"^) at a constant 10 volts. As 
previously found during electrophoretic insulin release (section
6.5.1.), a linear relationship was observed suggesting increased 
retardation of drug molecules by the polyacrylamide gel network as T 
is increased.
(c) Alteration of electric field conditions during delivery 
Figure 6.11 shows that at a constant 10 volts, and after a lag
time of approximately 5 hours, hyoscine methyl chloride was released 
through a 40T 7C polyacrylamide gel disc at a constant rate 
(3.3. x 10"® mol day"^). Removal of the electric field after 24 
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FIGURE 6.10 EFFECT OF TOTAL MONOMER CONCENTRATION 
(T) OF POLYACRYLAMIDE GEL ON ELECTRO­
PHORETIC RELEASE RATE OF HYOSCINE 























FIGURE 6.11 ELECTROPHORETIC RELEASE OF 
HYOSCINE METHYL CHLORIDE AT 
10 VOLTS AND ALTERNATING 10/0 
VOLTS THROUGH 40T 7C POLY­
ACRYLAMIDE GEL
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the above rate on re-applying the field at 4 8 hours. A second 
switching off of applied voltage at 72 hours again resulted in 
immediate cessation of drug release.
The above results indicate that gross morphological changes in 
polyacrylamide gel structure probably do not occur as a result of 
electrophoresis. The reproducibility of release rate during the 2 
periods of electrophoretic drug release suggest that as well as 
macromolecules such as insulin (section 6.5.1.), drugs of low 
molecular weight can also be electrophoretically released in a highly 
controllable manner through polyacrylamide gel.
(d) Temperature
A plot of current (at a constant 10 volts) versus temperature of 
electrophoretic release shows a linear relationship (figure 6.12). 
Figure 6.13 indicates an approximately linear relationship between 
temperature and hyoscine methyl chloride release rate. Both curves 
are analogous to those obtained during rod gel electrophoresis when 
the migration velocity of insulin-F was studied (section 5.3). It 
is believed that the causes of increased insulin-F migration velocity 
with rising temperature discussed above in section 53. are also 
responsible for the increase in hyoscine methyl chloride release rate 
with temperature.
(e) Polyacrylamide thickness
In figure 6.14 the effect of increasing polyacrylamide gel 
thickness on the electrophoretic release of hyoscine methyl chloride 
















FIGURE 6.12 EFFECT OF TEMPERATURE ON CURRENT 
DURING ELECTROPHORETIC RELEASE OF 







































FIGURE 6.13 EFFECT OF TEMPERATURE ON 
ELECTROPHORETIC HYOSCINE 
METHYL CHLORIDE RELEASE 
THROUGH 40T 7C POLYACRYL­

























FIGURE 6.14 EFFECT OF POLYACRYLAMIDE GEL THICKNESS ON 
ELECTROPHORETIC RELEASE OF HYOSCINE METHYL 
CHLORIDE AT A CONSTANT 10 VOLTS
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with decreasing gel thickness, since drug migration distance was 
reduced. From figure 6.14 drug release rate appears to be unaffected 
by gel thickness. However, electrophoretic release over longer 
periods than 24 hours would be expected to produce higher "apparent" 
release rates as gel thickness is reduced because of the increased 
contribution to release by drug permeation (sections 4.4.2. and 4.6.).
(f) Donor drug concentration
Figure 6.15 shows that a complex relationship exists between 
hyoscine methyl chloride release rate and change in donor drug 
concentration. The release rate (as a percentage fraction of donor 
concentration) from 2.82 x 10"4 and 2.82 x 10”3 mol dm-3 donor 
solutions was approximately equal, while from 2.82x 10”3 mol dm”3 
donor solution, a slower release rate was found.
The current flowing through the apparatus during 
the course of delivery was found to increase with increasing donor 
drug concentration due to the greater number of charge-carriers 
present. Mean currents were 2.0 mA, 3.0 mA and 3.5 mA for the 2.82x 
1CT5, 2.82 x 10"4 and 2.82 x 10”3 mol dm”3 donor drug solutions 
respectively. It is believed that the lower release rate from the 
2.82 x 10”5 mol dm”3 donor drug solution was due to the low current 
flowing during release and the expected differentiation between drug 
release rates from the more concentrated donor solutions on the basis 
of current flowing was not clear in this study.
Data from the highest donor drug concentration (2.82 x 10“ 2 
mol dm”3) is omitted because it was found to be highly irreproducible, 
in addition, a green colouration developed in the donor compartment, 
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FIGURE 6.15 EFFECT OF DONOR DRUG CONCENTRATION ON
ELECTROPHORETIC HYOSCINE METHYL CHLORIDE 
RELEASE THROUGH 40T 7C POLYACRYLAMIDE GEL 
AT A CONSTANT 10 VOLTS
186
have been reponsible for the errors detected in electrophoretic
delivery. No discoloration was observed in the more dilute donor
drug solutions during electrophoresis.
c
The relationship between hyosine methyl chloride release rate 
and donor drug concentration is not clear. It is believed that if 
the above study was repeated using donor solutions of equal ionic 
strength (and thus equivalent electric currents during 
electrophoresis), more useful results would be obtained.
(g) Duration of electrophoretic release
Figure 6.16 shows that hyoscine methyl chloride was 
electrophoretically released at a constant rate (3.5 x 10”® mol day” )^ 
up to approximately 150 hours, release rate then gradually falls. 
Interestingly, electric current (at 10 volts) in the release 
apparatus increased gradually from the start of delivery (2.2 mA) and ' 
reached a constant value of 4.8 mA after approximately 15 0 hours.
2-compartmental permeation experiments using membranes e.g. skin 
diffusion studies are generally discontinued once 1C% donor depletion 
has occurred since permeation rate decreases as donor concentration 
falls [215]. Similarly, electrophoretic release rate would be 
expected to decrease as depletion of the donor occurs. It is 
believed that the steadily increasing current maintained a constant 
release rate of hyoscine methyl chloride; when the current became 
more stable, drug release rate fell. The causes of electric current 



































FIGURE 6.06 ELECTROPHORETIC RELEASE OF HYOSCINE 
METHYL CHLORIDE THROUGH 40T 7C POLY­
ACRYLAMIDE GEL AT A CONSTANT 10 VOLTS
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(ill) Changes in electric current and electrolyte pH during hyoscine 
methyl chloride release
Electric current was found to increase during the course of 
hyoscine methyl chloride release. For example, at a constant 10 
volts, current typically increased from 2 mA to 4 mA over 72 hours 
thus giving a mean current for the run of 3 mA. This increase was 
believed to be due to (a) a reduction in polyacrylamide gel 
electrical resistance as drug passes into the gel disc and
(b) electrochemical reactions occurring at the electrodes.
The pH of the donor solution was found to decrease by less than 
one pH unit after 72 hours of electrophoresis at 10 volts while that 
of the receptor solution increased by approximately the same amount. 
Electrochemical reactions and ionic migration are believed to be 
mainly responsible for the observed pH changes which were considered 
to be within acceptable limits.
6.5.3. Electrophoretic release of hyoscine hydrobromide and 
propranolol hydrochloride
Electrophoretic release profiles for hyoscine hydrobromide and 
propranolol hydrochloride are shown in figures 6.17 and 6.18 
respectively.
Mean delivery currents were found to be 3.1+0.2 mA (5 volts) and 
4.5+1.6 mA (10 volts) during hyoscine hydrobromide release and 
4.2+0.6 mA (5 volts) and 8.5+1.2 mA (10 volts) during the release of 
propranolol. Current was observed to gradually increase during the 
































FIGURE 6.17 ELECTROPHORETIC RELEASE OF HYOSCINE 
HYDROBROMIDE THROUGH 40T 7C POLY­
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FIGURE 6.18 ELECTROPHORETIC RELEASE OF PROPRANOLOL 
HYDROCHLORIDE THROUGH 40T 7C POLYACRYL­
AMIDE GEL AT 5 AND 10 VOLTS
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Hyoscine hydrobromide was found to be released at a constant 
rate by applying 5 volts (0.8 x 10"® mol day”1) or 10 volts (2.4 x 
10”® mol day”1) for up to 96 hours; linear correlation coefficients 
were 0.990 (5 volts) and 0.988 (10 volts). A commercial system
[51,52] delivers hyoscine hydrobromide to the skin at a rate of 
approximately 0.4 x 10”® mol day”1. It is believed that a similar 
rate could be achieved using electrophoretically controlled hyoscine 
hydrobromide release by (i) decreasing donor drug concentration
(ii) reduction of the applied voltage to below 5 volts and (iii) by 
manipulation of polyacrylamide gel formulation and dimensions.
Propranolol hydrochloride was released (at zero-order) at 3 3 x 
10"5 mol day"1 (10 volts) and at 0.9 x 10"5 mol day"1 (5 volts); 
linear correlation coefficients were 0.999 (5 volts) and 0.995 (10 
volts). Daily propranolol hydrochloride dose (by slow I.V. 
injection) is between 0.3 x 10"® mol and 3.4 x 10"® mol [193].
The above results indicate that both propranolol hydrochloride 
and hyoscine hydrochloride may be released at constant rates 
electrophoretic ally; the _in vitro delivery of the latter to human 
skin was investigated (section 7).
Under similar electrophoretic conditions propranolol appears to 
be released at a greater rate than hyoscine hydrobromide, this was 
because a higher donor concentration of the former was initially 
present - fractions released were similar (figures 6.17 and 6.18).
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7. IN VITRO ELECTROPHORETIC DELIVERY OF HYOSCINE HYDROBROMIDE TO 
HUMAN SKIN USING A 3-COMPARTMENT MODEL
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7. In vitro electrophoretic delivery of hyoscine hydrobromide to 
human skin
Results obtained from 2-compartmental electrophoretic release 
studies (section 6.5) indicated that electrophoresis was potentially 
useful as an energy source for producing true controlled drug 
delivery. The in vitro controlled delivery of hyoscine hydrobromide 
to human skin was therefore investigated.
Drugs exhibiting transdermal penetration are usually most 
permeable in the unionized form (section 1.2.4.2.). However, ionized 
drug is required for electrophoresis; thus a 3-compartmental model 
utilising a multiphasic buffer system was proposed.
7.1. 3-Compartmental _in vitro model for delivery of hyoscine 
hydrobromide to human skin
The delivery apparatus was constructed from 6 mm thickness 
perspex and is represented schematically in figure 7.1. Three 
chambers were clamped together in series, each sealed with a lid 
which was secured using brass bolts. Chambers 1 (drug reservoir) and 
3 (receptor) were of equal capacity (150 cm^) whilst compartment 2 
had a lower capacity of 20 cra^ . PTFE stirring paddles rotating at 
240 r.p.m. ensured solution mixing within each compartment. A 
section of human skin (section 2.1.4.) was held between compartments 
2 and 3 with the stratum corneum surface exposed in the former. A 
rubber 'O' ring provided effective sealing and resulted in a circular 
skin permeation area of approximately 4 cm^. A polyacrylamide gel 
disc of 10 mm thickness was held between chambers 1 and 2.
Compartment 2 contained hyoscine hydrobromide (pKa 7 3 5) 










GEL DISC STIRRING PADDLECOMPARTMENT 2
(BUFFERED AT pH 9.7)
FIGURE 7.1 3-COMPARTMENTAL APPARATUS FOR IN VITRO ELECTROPHORETIC DRUG DELIVERY 
TO HUMAN SKIN
the unionized form thereby maximising its permeation through the skin 
section and into the receptor compartment which was buffered at pH 
7.4.
Chamber 1 formed a hyoscine hydrobromide reservoir and was 
buffered at pH 3.0 to ensure complete ionization of the drug. A 
circular platinized (section 6.1.) electrode was embedded in the wall 
of the reservoir chamber and a second, circumjacent to the skin 
membrane in compartment 2.
It was intended that as drug concentration in compartment 2 
became depleted through skin permeation, that hyoscine hydrobromide 
should be electrophoretically released from the reservoir at a rate 
equal to the transdermal flux. Thus drug concentration in 
compartment 2 would remain constant and provided that adequate sink 
conditions were maintained in the receptor, drug flux would be 
sustained at a constant level.
On the basis of results obtained from hyoscine methyl chloride 
electrophoretic release studies (section 6.5.2.) it was postulated 
that desired hyoscine hydrobromide delivery rates could be achieved 
by manipulation of donor drug solution concentration and 
electrophoretic voltage.
Initially, however, the effect of donor drug concentration and 
pH upon the transdermal permeation of hyoscine hydrobromide, the 
effectiveness of the proposed buffering system and drug stability at 
the proposed pH's were investigated in order to select appropriate 
conditions for the 3-compartmental study.
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7.1.1. In vitro permeation of hyoscine hydrobromide through 
human skin
7.1.1.1. Apparatus for skin permeation studies
An infinite dose technique (section 1.2.4 3.) was employed using 
perspex permeation cells (figure 7 3.) similar to those employed by 
Patel and Foss [5 9]. Epidermis was clamped between the 2 halves 
(each of 7 ml capacity) of the cell, a rubber 'O' ring on the stratum 
corneurn side of the membrane ensured effective sealing; exposed skin 
area in each compartment was 4.9 cm^. Samples were withdrawn through 
sampling ports otherwise sealed with PTFE coated stoppers.
7.1.1.2 Preparation of epidermal sections for permeation 
experiments
Only relatively non-hairy abdominal cadaver skin samples were 
used from which afull thickness skin* membranes composed of stratum 
corneum, epidermis and some dermis were prepared according to a 
method described by Walters [5 8].
Skin samples were pinned, stratum corneum side down, and 
excess fat trimmed away leaving strips of uniform thickness. 
Specimens were then placed into distilled water at 6 0°C for 
precisely 2 minutes prior to being pinned down once more with 
the stratum corneum side facing upwards. The epidermis was 
cut across the membrane strip and carefully separated from 
the lower layers of skin using forceps. Full thickness skin 
membrane was then floated in distilled water onto a sheet of 
aluminium foil and left to dry for several hours before 
storage in sealed polythene bags at -5°C. Skin samples were 
used within one month. Before location into permeation
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FIGURE 7.2 2-COMPARTMENT APPARATUS FOR IN VITRO SKIN PERMEATION STUDIES
cells, epidermal membranes were thawed out by placing them 
in distilled water for several hours; after this time, they 
could be separated from the aluminium foil sheets with ease 
and without damage.
7.1.1.3. General method for skin permeation studies
The permeation apparatus and donor and receptor solution were 
equilibrated to 3 0°C in a waterbath. 7 cm3 of each solution 
was introduced into the appropriate chamber of the permeation 
cell simultaneously by means of glass pipettes so as to avoid 
undue distention of the epidermis. 1 x 10”3M phosphate 
buffer, pH 7.4, was employed in the receptor compartment, 
throughout the study; pH and simple electrolyte gradients 
across skin have been shown not to significantly affect drug 
permeability [3 9].
After ensuring the absence of air bubbles within the 
chambers by visual inspection, the permeation cell was placed 
into a 3 0+0.1°C waterbath shaking at 120 cycles per minute to 
ensure solution agitation. Samples of 1 cm3 were withdrawn 
from the receptor solution at timed intervals and replaced 
with an equal volume of the appropriate solvent; the dilution 
was subsequently accounted for when calculating permeation 
data. Unless assayed immediately, samples were stored at 4°C 
prior to determination of hyoscine hydrobromide concentration 
using HELC (section 2.2.5). The increase in drug 
concentration within the receptor compartment was monitored 
for approximately 4 days, during which time the decrease in
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donor drug concentration was also routinely monitored.
On completion of permeation experiments, the integrity of the 
epidermal section was assessed by introducing a small volume of a 
non-permeating molecule - radiolabelled hyoscine methyl chloride 
solution into the donor compartment. Appearance of radioactivity, 
assayed by scintillation counting (section 2.2 3.) in the receptor 
compartment was taken to be indicative of the presence of 
perforations or other damage to the membrane and data was discarded. 
Hyoscine methyl chloride was not found, during the present study, to 
permeate through intact epidermis to a detectable extent.
Due to difficulties in obtaining cadaver skin, each 
determination was performed in triplicate only. Skin samples were 
assigned to particular experiments on a purely random basis.
7.1.13.1. The influence of donor drug solution concentration and pH 
on the in vitro skin permeation of hyoscine hydrobromide
Michaels et al. [3 9] and Chandrasekaran [42] found that hyoscine 
hydrobromide permeated well through human skin (during in vitro 
studies) from donor solutions at pH 9.6; drug permeation was found to
increase with increasing donor drug concentration, also at pH 9.6.
—5 — 3For this study, hyoscine hydrobromide (238 x 10 mol dm ) at 
pH 3.0 and 6.0, using citrate-phosphate buffer, 0.04M, and at pH 9.7 
with 0.04 M borate buffer, were used as donor solutions.
Donor drug solutions of various concentrations: 2.2 8 x 10“ ,^
1.14 x 10-3 and 2.8 x 10"3 mol dm-3 were prepared by dissolving 
hyoscine hydrobromide in 0.04M borate buffer, pH 9.7. Hyoscine 
hydrobramide flux through human skin was calculated using the method
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described in section 1.2.4.3.
7.U2. Determination of the extent of hyoscine hydrobromide 
loss during storage at pH 3.0 and 9.7
Hyoscine hydrobromide was dissolved in 0.04M citrate-phosphate 
buffer, pH 3.0 and 0.04M borate buffer, pH 9.7 to produce drug 
solutions of 2.2 8 x 10“4 mol dm-3. 150 ml of each solution was
placed into a volumetric flask, protected from light and kept in a 
water bath maintained at 30+0.1°C. Solutions were assayed for 
hyoscine hydrobromide using HHLC (section 2.2.5) before, after 4 
days, and following storage for 2 weeks, and compared with freshly 
prepared hyoscine hydrobromide solutions.
7.13. Buffer pH stability during 3-compartmental electrophoretic 
drug delivery
The 3-compartmental apparatus (described in section 7.1.) 
incorporating a 40T 7C polyacrylamide gel disc and full thickness 
human skin was used to assess pH stability during electrophoretic 
drug delivery. 1 x 10_3M phosphate buffer was used in compartment 3 
throughout the determination. Compartments 1 and 2 were buffered at 
pH's 3.0 and 9.7 respectively but using buffers of equal ionic 
strength. Citrate-phosphate buffer (chamber 1) and borate buffer 
(chamber 2) of 1 x 10“3M, 4 x 10~3M and 1M ionic strengths were used.
After approximately 100 hours of electrophoresis, at a constant 
10 volts and with the apparatus maintained at 3 0+0.1°C, the pH of 
each compartment was determined.
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7 .2 • Results and discussion
Drug permeation profiles similar to those expected (section 
1.2.4 3.) were obtained during hyoscine hydrobromide skin permeation 
studies. Lag times varied between 1.4 and 8 hours with shorter lag 
times generally associated with greatest rates of skin permeation.
Figure 7A shows that the rate of _in vitro permeation of 
hyoscine hydrobromide increased with increasing donor solution pH.
This is similar to the findings of Michaels et al. [39] who observed 
that unionized hyoscine hydrobromide was nearly 20 times more 
permeable in human skin than ionized drug. During this study, the 
greatest and lowest permeation rates were found when hyoscine 
hydrobromide (pKa 7 35) was either completely in the unionized (pH 
9.7) or ionized forms (pH 3.0) respectively. An intermediate 
permeation rate was found at pH 6.0 when the drug was assumed to be 
approximately .96% ionized.
Figure 7 3 indicates a linear relationship between donor drug 
solution concentration and the _in vitro flux of hyoscine hydrobromide 
through human skin. Increased drug donor concentration was expected 
to produce greater drug flux since the diffusive permeation process 
relies upon the concentration gradient across the membrane, which is 
greatest at high donor concentrations.
The observed permeation rates are lower than those found by Shaw 
and Chandrasekaran who studied hyoscine permeation through stomach 
skin [50] and found permeation rates of approximately 2 x 10“® mol 
cm“2 hr"^ compared with 2 x 10”® mol cm"^ hr“^ obtained during this 
study. However, their permeation experiments utilized hyoscine free 
base in mineral oil at a concentration of 4.7 mg g“^ as the donor.
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FIGURE 7.3 EFFECT OF DONOR DRUG CONCENTRATION 
ON IN VITRO HYOSCINE HYDROBROMIDE 
FLUX THROUGH HUMAN ABDOMINAL 
EPIDERMIS AT pH 9 . 7
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FIGURE 7.4 EFFECT OF DONOR pH ON LN VITRO 
HYOSCINE HYDROBROMIDE FLUX 
THROUGH HUMAN ABDOMINAL EPIDERMIS
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permeation experiments at pH 9.7.
Storage of hyoscine hydrobromide solution at pH 3.0 for 2 weeks 
resulted in no detectable drug loss. However, approximately 90% of 
drug remained after 4 days with approximately 6C% remaining after 2 
weeks of storage at pH 9.7. Hyoscine hydrobromide instability in 
solution has been reported; the free bases of alkaloids are 
considered to be unstable [216].
Thus the excessive donor drug depletion found during this study 
was probably due to hyoscine hydrobromide breakdown at pH 9.7. 
Although different buffers may have been used, Michaels et al. [39] 
did not discuss the possibility of donor drug degradation and in fact 
stated that donor drug concentration was not routinely monitored 
during hyoscine hydrobromide permeation experiments.
No degradants were detected during HELC assay for hyoscine 
hydrobromide and the possibility of drug depletion by adsorption onto 
vessel walls was not eliminated. Whatever the mechanism of donor 
drug loss, the results of hyoscine hydrobromide skin permeation 
obtained in the present study cannot be utilised as absolute values.
In studies of pH stability of buffers intended for 
3-compartmental delivery investigations, the pH in compartment 3 
remained unchanged after electrophoresis runs. There was a decrease 
of approximately 1 pH unit in compartment 1 (anolyte) and an increase 
of between 2 and 3 pH units in compartment 2 (catholyte). A 
previously observed trend of increased effectiveness of buffer with 
increasing buffer ionic strength (section 6.4.1.) was not found. The 
directions of pH changes observed were as expected from consideration 
of electrolytic processes occurring (section I.5.4.4.V.) during
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electrophoresis but the buffering arrangement utilised in this study 
probably gave rise to complex electrochemical reactions which 
manifested as the observed pH changes.
Hyoscine hydrobromide was shown to permeate through human skin in 
vitro. The rate of permeation was dependent upon donor drug solution 
concentration and pH. However conditions of pH favourable to drug 
permeation appeared to be detrimental to drug stability. Adequate 
buffering of the 3-compartmental model for studying electrophoretic 
drug delivery to skin was not achieved and pH changes, probably due 





Polyacrylamide gel rods, discs and sheets and polyHEMA gel rods 
could be prepared by chemically initiated polymerization using the 
methods described in this study. However, neither polyacrylamide or 
polyHEMA gels of an acceptable quality were produced by gamma- 
irradiation initiated polymerization during this study due to 
inadequate temperature control and lack of maintenance of monomer 
deaeration during preparation.
Rod polyacrylamide gel electrophoresis (PAGE) indicated that 
lower voltages than normally utilised in conventional PAGE techniques 
could be used to produce reproducible migration of proteins such as 
bovine serum albumin (BSA) and insulin. The electrophoretic 
migration of these proteins was influenced by polyacrylamide gel 
formulation, magnitude of applied voltage (field strength), 
temperature and electrolyte/gel buffer ionic strength and pH.
Rod gel electrophoresis using polyHEMA gel was unsuccessful for 
the electrophoresis of BSA and insulin; the electrophoretic passage 
of these molecules was probably restricted by the relatively small 
pore size of polyHEMA gels used compared with polyacrylamide gels 
employed.
Electron microscopy studies suggested that a heterogeneous 
polyacrylamide gel structure existed in the micron range; thus it was 
considered that any molecular sieving must occur within an 
infrastructure comprising pores approaching molecular dimensions.
Polyacrylamide gels were found to swell in water and citrate- 
phosphate buffer solutions but reached an equilibrium swelling after
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approximately 100 hours. The extent of polyacrylamide gel swelling 
was found to be influenced by polymerization temperature and gel 
formulation factors such as total monomer concentration and 
percentage crosslinking together with the ionic strength of the 
immersing buffer. Swelling of polyacrylamide gel was found to be 
negligible during electrophoresis.
U.V. absorbing materials, believed to be unreacted monomers and 
catalysts, were leached from polyacrylamide gels (produced by 
chemically initiated polymerization)during storage in buffer 
solution; the release rate of contaminants was high for the first 2 
days and then decreased markedly on further storage.
A 'solution depletion* technique used in this study to determine 
drug partition coefficients in polyacrylamide gels was unsuccessful; 
a source of interference may have been microbial contamination.
Hyoscine hydrobromide, propranolol hydrochloride, hyoscine 
methyl chloride and insulin were found to permeate through 
polyacrylamide gel, probably via a "pore mechanism*. The permeation 
of these drugs was found to be influenced by polyacrylamide gel 
formulation, decreasing as gel monomer concentration was increased 
and showing a minimum at 6-8% crosslinking (C) with Bis.
The permeation of the above drugs may be minimized by 
manipulation of polyacrylamide gel formulation and by increasing gel 
thickness. Thus polyacrylamide gel discs were used to provide a 
barrier to drug permeation from a reservoir solution.
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By application of an electric field, drugs of both high 
molecular weight such as insulin and low molecular weight such as 
hyoscine hydrobromide, propranolol hydrochloride and hyoscine methyl 
chloride, could be eluted from the reservoir solution. By use of a 
stabilized power supply to provide constant low voltage conditions (5 
and 10 volts), the above drugs were released at constant rates (zero- 
order) for several days. In addition, insulin and hyoscine methyl 
chloride were found to be released in a reproducible manner, 
intermittently, by removal and re-application of the electric field. 
Drug release rates were found to be affected by the strength of 
electric field applied, temperature and polyacrylamide gel 
formulation. Ionic migration and electrolysis gave rise to pH 
changes during electrophoretic drug release .
Hyoscine hydrobromide was found to permeate through human skin 
in vitro, the permeation rate was. influenced by donor drug solution 
pH and concentration. However, at pH 9.7 (which was favourable to 
skin permeation) hyoscine hydrobromide loss (probably through 
degradation) occurred.
A three-compartmental model intended for the study of controlled 
in vitro hyoscine hydrobromide delivery to human skin was not 
completely successful due to problems of drug stability and pH drift 
during electrophoresis.
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Suggestions for further work
Polyacrylamide gel was found to be permeable to drugs used in this 
study. Investigation of alternative polymers capable of preventing 
drug permeation yet permitting electrophoretic drug elution may lead 
to improved control of drug release; in addition, absence of residual 
chemicals and minimal or no swelling in use would be desirable 
properties.
Constant voltage power supplies were used throughout this study. 
However, a constant current source with microprocessor control to 
produce currents in the micro- and milliamp range was constructed but 
not validated. Electrophoretic drug release studies using this 
constant current source may produce more reproducible drug release 
than found in the present study by overcoming the effects of 
changes in electrical resistance within the electrophoretic 
apparatus.
The problem of pH control during this study requires further 
study and may be reduced or eliminated by the use of alternative 
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The labelling of proteins for electrophoresis with a fluorescent 
marker
Fluorescamine was first used as a fluorescent marker for the 
detection of primary amines by Udenfriend et al. [119] based on its 
chemical properties. The reaction of fluorescamine with primary 
amines is completed within a few seconds at room temperature








A method similar to that first described by Eng and Parkes [188] for 
the fluorescamine labelling of proteins for electrophoresis was used 
in this study to label insulin and bovine serum albumin for rod gel 
electrophoresis:
1) 2.5 x 10~2 g of protein was dissolved in 25 cm3 of 0.025M 
phosphate buffer at pH 7 .4.
2) 1 cm3 of a 0.1% (w/v) solution of fluorescamine in acetone 
was added and the mixture shaken briefly. Fluorescence was 
seen to develop during the shaking procedure.




Reproducibility of delivery by automatic replicating pipettes and 
bottle dispensing pipette
Variable volume replicating pipettes (Gilson Pipetman, PI00,
P200, P1000 and P5000, Anachem) were used throughout this study for 
delivery of liquids in the range 20 urn3 to 5 cm3. The reproducibility 
of delivery was assessed by weighing 10 consecutive deliveries of 
nominal volumes of distilled water? the following volumes were 
weighed using a 4 figure analytical balance (Mettler H15). 2 0, 40,
6 0, 8 0, 100, 15 0, 2 00, 4 00, 6 00, 8 00, 1000, 2 000, 3 000, 4 000 and 5000 
urn3. The coefficient variation did not exceed 0.69% in the range 100 
to 5000 urn3 and was less than 1.87% in the range 20 to 100 urn3 .
3
To assess the reproducibility of delivery of a nominal 4 cm 
volume of scintillation fluid using a bottle dispensing pipette 
(Oxford dispenser IV), 5 consecutive deliveries of scintillant 
(section 2.2.3.) were weighed and the coefficient of variation for 
delivery was found to be 0.15%.
On the basis of the above results, it was considered that the 
reproducibility of delivery by automatic replicating and bottle 
pipettes was satisfactory.
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